Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010380	li-borrabg	— (—)	4960	5325	100.00%	Distribution not available
3010380	li-borrabg	AU/ml (au/ml)	37	44	0.00%
3010380	li-borabgv	— (—)	31	33	100.00%	Distribution not available
3010380	li-borabgv	AU/ml (au/ml)	17	17	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Concussion

541

600

7.09

319.07

1.1

1.0

16.00

77.72

au/ml

—

Visual disturbances and blindness

932

2418

3.94

312.57

1.1

34.77

70.38

au/ml

—

Neurological diseases

1322

803

8.43

307.65

1.1

1.0

45.31

66.38

au/ml

—

Demyelinating diseases of the central nervous system

688

370

22.48

307.65

1.1

—

87.48

—

Symptoms and signs involving the nervous and musculoskeletal systems

1316

2456

5.54

307.65

1.1

59.65

66.51

au/ml

0.11

General symptoms and signs

1467

2167

3.44

307.65

1.1

44.10

82.22

au/ml

0.92

Polyneuropathies and other disorders of the peripheral nervous system

569

755

7.92

307.65

1.1

91.63

35.17

au/ml

1.48

Symptoms and signs involving cognition, perception, emotional state and behaviour

1570

2984

3.58

307.65

1.1

55.42

75.03

au/ml

0.40

Disturbances of skin sensation

784

1320

6.22

307.65

1.1

37.50

64.08

au/ml

—

Headache

1230

2032

4.78

307.65

1.1

72.87

92.25

au/ml

0.32

Other symptoms and signs involving the nervous and musculoskeletal systems

959

1773

5.60

307.65

1.1

73.94

64.24

au/ml

—

Other and unspecified polyneuropathies, also in other diseases

482

641

7.89

307.65

1.1

91.45

35.17

au/ml

1.34

Intracranial trauma

588

607

6.63

306.53

1.1

1.0

18.50

77.73

au/ml

—

Visual disturbances

886

2262

4.02

304.67

1.1

34.77

73.65

au/ml

—

Other neurological diseases

1086

2440

3.51

287.78

1.1

39.33

70.94

au/ml

—

Malaise and fatigue

757

1409

4.30

266.56

1.1

21.77

80.41

au/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

1095

3383

3.11

251.96

1.1

63.58

70.30

au/ml

0.11

Autoimmune diseases related-to ILD

1243

3591

2.93

251.26

1.1

66.92

70.15

au/ml

—

Epilepsy

551

1151

4.90

244.40

1.1

12.78

88.78

au/ml

—

Autoimmune diseases excluding thyroid diseases, strict definition

1380

2694

2.82

230.09

1.1

59.36

64.60

au/ml

0.09

Autoimmune diseases excluding thyroid diseases

1412

2782

2.79

229.81

1.1

60.16

63.94

au/ml

0.07

ILD medications: immunosuppressive drugs

929

2790

3.06

206.82

1.1

41.54

76.41

au/ml

—

Fever of other and unknown origin

726

1780

3.58

205.80

1.1

64.37

76.80

au/ml

0.20

Condition for Implicit Sepsis (Organ dysfunction codes)

1129

2791

2.84

205.15

1.1

60.58

68.45

au/ml

—

Implicit Sepsis, including avohilmo

1089

2773

2.84

200.08

1.1

65.42

67.10

au/ml

—

ILD medications

1434

3067

2.55

197.38

1.1

47.81

75.59

au/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1176

2979

2.70

193.12

1.1

60.58

73.84

au/ml

—

Dizziness and giddiness

931

2485

2.95

187.39

1.1

59.92

78.95

au/ml

—

Episodal and paroxysmal disorders

1278

2563

2.55

173.79

1.1

41.61

70.42

au/ml

—

Migraine

756

1894

3.16

170.16

1.1

—

76.91

—

Motor neuron disease (with DMD)

81.71

164.82

1.0

1.1

—

Implicit Sepsis

952

2597

2.73

164.46

1.1

65.42

66.07

au/ml

—

Motor neuron disease ALS

81.02

162.72

1.0

1.1

—

Autoimmune diseases

1284

2792

2.36

148.04

1.1

48.88

63.94

au/ml

0.30

Cerebrovascular diseases

835

2141

2.74

142.40

1.1

82.89

67.13

au/ml

—

Viral Sepsis

343

762

4.62

142.12

1.1

44.36

67.11

au/ml

—

Used for control exclusion in common control thyroid runs

1198

2552

2.39

142.09

1.1

53.17

63.49

au/ml

—

Implicit viral Sepsis

340

760

4.59

139.79

1.1

44.36

67.11

au/ml

—

Medical observation and evaluation for suspected diseases and conditions

757

1299

3.01

138.61

1.1

64.29

63.22

au/ml

—

Other soft tissue disorders, not elsewhere classified

1134

2772

2.35

134.54

1.1

65.32

64.37

au/ml

—

Implicit viral Sepsis, including avohilmo

440

1218

3.68

134.32

1.1

44.63

81.96

au/ml

—

Nerve, nerve root and plexus disorders

1239

3351

2.24

134.07

1.1

67.27

67.74

au/ml

0.01

ILD medications: prednisolone, methylprednisolone, prednisone

1206

2999

2.25

129.68

1.1

47.81

75.59

au/ml

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

772

2640

2.57

123.72

1.1

51.59

75.09

au/ml

—

Mood disorders, excluding more controls

1042

2661

2.32

121.76

1.1

84.40

65.83

au/ml

—

STROKE

696

1720

2.76

119.58

1.1

102.67

67.25

au/ml

—

Certain infectious and parasitic diseases

1035

2222

2.35

118.87

1.1

65.17

8.03

au/ml

—

Organic, including symptomatic, mental disorders

545

1285

3.02

111.47

1.1

64.00

60.94

au/ml

—

General examination and investigation of persons without complaint and reported diagnosis

688

1299

2.78

110.65

1.1

38.48

63.22

au/ml

—

Dorsalgia

1101

2673

2.20

110.54

1.1

56.15

82.51

au/ml

0.55

Low back pain

893

2603

2.34

109.95

1.1

78.21

82.51

au/ml

0.06

Benign intracranial hypertension

24.82

109.14

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

194

329

6.05

108.95

1.1

—

53.21

—

Pain in joint

642

1446

2.76

107.47

1.1

54.76

52.02

au/ml

—

Other antidepressants

1088

2564

2.18

106.14

1.1

52.75

67.78

au/ml

—

Depression

1091

3487

2.11

104.87

1.1

84.40

71.35

au/ml

—

Other dorsopathies, not elsewhere classified

1100

2682

2.15

103.59

1.1

54.22

79.63

au/ml

0.53

Pain in limb

946

2714

2.24

103.49

1.1

60.75

64.37

au/ml

—

Mood [affective] disorders

1135

3556

2.06

101.67

1.1

84.40

69.51

au/ml

—

Mood disorders

1136

3556

2.06

101.48

1.1

84.40

69.51

au/ml

—

Diseases of the eye and adnexa

897

1974

2.30

97.85

1.1

37.57

80.52

au/ml

—

Stroke, excluding SAH

608

1691

2.62

97.02

1.1

68.50

70.67

au/ml

—

Stroke, including SAH

636

1802

2.56

96.51

1.1

80.38

69.49

au/ml

—

First line medication for Crohn's disease

1190

3206

2.01

95.72

1.1

47.81

77.78

au/ml

—

Examination and observation for other reasons

608

1293

2.68

94.21

1.1

62.80

63.22

au/ml

—

Use of teriflunomide

21.35

93.59

1.0

1.1

—

Oral corticosteroids

1141

3373

2.00

92.14

1.1

60.37

76.29

au/ml

—

Ischaemic Stroke, excluding all haemorrhages

561

1573

2.65

92.07

1.1

68.50

73.49

au/ml

—

Migraine with aura

361

1129

3.25

91.49

1.1

—

45.75

—

Abnormal involuntary movements

212

465

4.68

89.54

1.1

—

58.34

—

Lower back pain or/and sciatica

1159

3718

1.95

88.91

1.1

79.14

65.48

au/ml

0.27

Second line medication for Crohn's disease

683

3024

2.28

86.59

1.1

53.50

64.55

au/ml

—

Inflammatory bowel disease treatment related agents

1209

3511

1.92

86.53

1.1

47.81

76.29

au/ml

—

L04AX Other immunosuppressants

662

2923

2.29

84.61

1.1

53.50

64.55

au/ml

—

Other special examinations and investigations of persons without complaint or reported diagnosis

638

1299

2.51

84.34

1.1

75.35

63.22

au/ml

—

Implicit bacterial Sepsis, including avohilmo

467

1456

2.70

81.68

1.1

95.80

74.30

au/ml

—

Opioids

1026

2675

2.00

79.99

1.1

39.84

73.78

au/ml

—

Recurrent or chronic depression

451

1136

2.79

79.95

1.1

113.40

73.01

au/ml

—

Migraine without aura

303

929

3.32

79.52

1.1

—

49.00

—

Codeine

968

2634

2.00

77.01

1.1

68.70

73.78

au/ml

—

Dorsopathies

1036

2699

1.96

76.24

1.1

27.71

79.63

au/ml

1.87

Dysphagia

301

954

3.20

74.74

1.1

24.24

79.10

au/ml

—

Implicit bacterial Sepsis

417

1338

2.70

73.77

1.2

1.1

95.80

76.61

au/ml

—

Syncope and collapse

405

1245

2.74

73.36

1.1

33.90

82.13

au/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

587

2620

2.25

71.69

1.1

64.40

66.39

au/ml

—

Psychiatric diseases

916

2323

1.99

70.33

1.1

69.40

66.81

au/ml

—

Pain (limb, back, neck, head abdominally)

659

1466

2.27

70.32

1.1

56.73

50.08

au/ml

—

Bacterial Sepsis

456

1524

2.50

68.42

1.1

95.80

74.30

au/ml

—

Other intervertebral disc disorders

797

2364

2.02

67.30

1.1

37.71

82.51

au/ml

—

Tramadol

781

2343

2.02

65.59

1.1

59.80

73.78

au/ml

—

Extrapyramidal and movement disorders

406

1619

2.54

65.53

1.1

71.32

70.27

au/ml

—

Soft tissue disorders

1009

2797

1.86

64.24

1.1

32.26

62.85

au/ml

—

Care involving use of rehabilitation procedures

662

2919

2.06

63.67

1.1

—

74.80

—

Pain in throat and chest

860

2685

1.91

61.48

1.1

27.24

64.19

au/ml

—

GASTRO-related operations

780

1971

2.00

60.88

1.1

82.70

75.24

au/ml

—

Any gastric operation

780

1971

2.00

60.88

1.1

82.70

75.24

au/ml

—

Sciatica+with lumbago

526

2130

2.21

60.50

1.1

85.33

85.94

au/ml

—

Benzodiazepine use

1001

3820

1.78

59.09

1.1

42.03

74.56

au/ml

—

Persons encountering health services for examination and investigation

571

1299

2.22

58.14

1.1

39.52

63.22

au/ml

—

Bacterial infection, other or unspecified

522

2036

2.18

57.91

1.1

43.80

72.81

au/ml

—

Other extrapyramidal and movement disorders in other diseases

287

1028

2.84

57.56

1.1

83.38

77.14

au/ml

—

Other acute disseminated demyelination

15.19

57.34

1.2

1.1

—

Codeine or tramadol medication

1096

3449

1.74

56.72

1.1

68.70

66.92

au/ml

—

Bacterial infection, other or unspecified, including avohilmo

567

2246

2.09

55.74

1.1

43.80

72.81

au/ml

—

Parasetamol

724

1858

1.98

55.53

1.1

33.72

76.89

au/ml

—

Symptoms and signs involving the circulatory and respiratory systems

981

2772

1.78

54.62

1.1

67.24

62.97

au/ml

—

Certain infectious and parasitic diseases, including avohilmo

646

1591

2.05

53.91

1.1

72.74

7.70

au/ml

—

Use of peginterferon beta-1a

27.39

53.13

1.1

1.2

—

Other specific joint derangements/joint disorders

789

2667

1.86

52.57

1.1

77.88

73.78

au/ml

0.06

Other and unspecified degenerative diseases of nervous system

9.71

50.50

1.1

1.0

—

Neuromuscular dysfunction of bladder

136

338

4.13

49.11

1.0

1.1

—

46.88

—

Systemic connective tissue disorders

359

1553

2.34

48.59

1.1

49.26

74.88

au/ml

—

Spondylopathies

676

2117

1.90

47.87

1.1

56.98

82.51

au/ml

0.50

Asthma, excluding more controls

682

1841

1.91

47.62

1.1

30.80

76.84

au/ml

—

Cardiovascular diseases (excluding rheumatic etc)

703

2158

1.88

47.57

1.1

32.20

64.55

au/ml

—

Other lack of coordination

10.78

47.48

1.1

—

Asthma

692

1891

1.90

47.30

1.1

30.80

82.12

au/ml

—

Somatoform disorder

213

727

2.98

46.86

1.1

—

89.29

—

Symptoms and signs involving the digestive system and abdomen

898

2602

1.74

46.04

1.1

82.73

63.63

au/ml

—

Asthma (mode)

680

1906

1.89

45.75

1.1

37.83

82.12

au/ml

—

Migraine without aura and triptan purchases

244

908

2.74

45.72

1.1

—

60.63

—

Migraine with aura and triptan purchases

236

877

2.74

44.37

1.1

—

55.00

—

Disorders of vestibular function (Vertigo)

436

2073

2.07

43.36

1.1

51.96

72.25

au/ml

—

Non-invasive ventilation

259

876

2.58

42.21

1.1

—

81.16

—

Symptoms and signs involving the urinary system

682

2917

1.77

41.01

1.1

59.46

65.87

au/ml

—

Hard cardiovascular diseases

730

2474

1.75

40.17

1.1

57.50

75.52

au/ml

—

Viral infections characterized by skin and mucous membrane lesions

434

2188

2.00

39.66

1.1

50.40

68.97

au/ml

—

Influenza and pneumonia

989

3828

1.60

39.13

1.1

36.62

78.08

au/ml

1.28

Abdominal and pelvic pain

863

2602

1.67

38.76

1.1

93.39

63.63

au/ml

—

Diseases of inner ear

482

2426

1.91

38.60

1.1

51.96

71.02

au/ml

—

Cervicalgia

213

807

2.67

38.49

1.1

—

103.36

—

Nonorganic sleeping disorders, excluding more controls

230

907

2.57

38.32

1.1

—

61.06

—

Other bacterial diseases

827

3328

1.65

37.75

1.1

73.66

72.57

au/ml

—

798

2789

1.68

37.74

1.1

36.62

85.40

au/ml

1.48

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

798

2789

1.68

37.74

1.1

36.62

85.40

au/ml

1.48

Follow-up examination after treatment for conditions other than malignant neoplasms

353

1095

2.16

36.70

1.0

1.1

—

69.45

—

Other disorders of binocular movement

7.03

36.02

1.1

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

885

3734

1.60

36.01

1.1

29.61

75.69

au/ml

—

Monoplegia

9.11

35.68

1.1

—

Other joint disorders

847

2710

1.64

35.45

1.1

47.78

71.17

au/ml

—

Personality disorders, excluding more controls

269

1178

2.30

35.36

1.1

—

77.83

—

Persons encountering health services in other circumstances, wide

1003

3304

1.57

34.94

1.1

57.63

70.43

au/ml

—

Fibromyalgia

124

371

3.41

34.24

1.1

—

97.52

—

Spondylosis

436

1786

1.92

34.08

1.1

75.10

82.51

au/ml

—

Use of glatiramer acetate

7.60

33.49

1.1

—

Paraplegia, diplegia of upper limbs

7.31

33.38

1.1

—

Intracranial injury

537

2859

1.76

32.83

1.1

17.43

73.46

au/ml

—

Acute upper respiratory infections of multiple and unspecified sites

711

3177

1.64

32.17

1.1

76.46

79.33

au/ml

—

COPD/asthma related infections

879

2789

1.59

32.07

1.1

30.25

85.40

au/ml

—

COPD/asthma/ILD related infections

879

2789

1.59

32.07

1.1

30.25

85.40

au/ml

—

Exclusions for E4_PCOS_BROAD

209

859

2.47

32.00

1.2

1.1

85.40

54.37

au/ml

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

829

4120

1.57

31.95

1.1

102.13

63.82

au/ml

—

Fasciculation

10.22

31.90

1.0

1.1

—

Herpesviral [herpes simplex] infections

148

514

2.93

31.77

1.1

—

65.47

—

Other diseases of urinary system

858

3064

1.58

31.55

1.1

41.80

71.94

au/ml

—

Dyspnoea

788

3590

1.59

31.47

1.1

129.50

63.30

au/ml

—

Acute upper respiratory infections

904

3503

1.55

31.39

1.1

53.62

74.01

au/ml

0.54

Migraine, single triptan purchase ok & required. ICD-code if available is included

731

3073

1.62

31.02

1.1

65.86

74.74

au/ml

—

Triptan medication for migraine, single purchase ok

731

3073

1.62

31.02

1.1

65.86

74.74

au/ml

—

Other functional intestinal disorders

415

2031

1.87

30.77

1.1

64.72

51.59

au/ml

—

Disorders of eyelid, lacrimal system and orbit

754

3482

1.59

30.42

1.1

48.99

75.53

au/ml

—

Substance abuse, excluding more controls

454

2102

1.81

30.28

1.1

—

55.56

—

Diseases of the ear and mastoid process

1012

3361

1.51

30.26

1.1

41.98

77.65

au/ml

—

Other bacterial diseases, including avohilmo

884

3587

1.54

30.24

1.1

53.26

72.34

au/ml

—

Shoulder lesions

618

2204

1.69

30.07

1.1

61.00

68.76

au/ml

—

Postviral fatigue syndrome

10.94

29.61

1.1

—

Other diseases of intestines

960

3540

1.52

29.56

1.1

85.20

60.70

au/ml

—

Metabolic disorders

812

3120

1.57

29.45

1.1

59.42

75.37

au/ml

—

Injuries to the head

987

3931

1.50

28.79

1.1

15.29

78.72

au/ml

—

Pneumonia, organism unspecified

798

3540

1.55

28.45

1.1

46.71

79.59

au/ml

0.85

957

3233

1.51

27.99

1.1

44.80

77.33

au/ml

1.11

Bronchitis

947

3808

1.50

27.89

1.1

76.46

67.50

au/ml

—

Polyuria

203

881

2.33

27.57

1.1

—

60.82

—

Dermatitis

551

3263

1.66

27.52

1.1

47.19

74.87

au/ml

—

Diseases of oesophagus, stomach and duodenum

918

3623

1.50

27.35

1.1

59.87

70.20

au/ml

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

931

3302

1.50

27.32

1.1

35.52

70.43

au/ml

—

Sleep disorders (combined)

935

3264

1.50

27.19

1.1

24.24

67.42

au/ml

—

Visual impairment including blindness (binocular or monocular)

210

3.88

26.94

1.2

1.1

—

Fall on same level

1013

3681

1.47

26.86

1.1

74.79

72.09

au/ml

—

Gastro-oesophageal reflux disease

588

3054

1.63

26.85

1.1

76.24

73.54

au/ml

—

Constipation

745

3270

1.55

26.39

1.1

100.08

66.79

au/ml

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

461

2600

1.72

26.22

1.1

52.20

75.65

au/ml

—

Abnormalities of heart beat

314

1591

1.93

25.98

1.1

98.40

58.60

au/ml

—

Diseases of the respiratory system

529

1559

1.71

25.92

1.1

62.74

88.39

au/ml

—

All pneumoniae

888

3890

1.49

25.87

1.1

43.73

78.08

au/ml

0.98

Finngen Rheumatological endpoints

854

3226

1.51

25.84

1.1

51.56

74.50

au/ml

—

Pneumonias (Asthma/COPD co-morbidities)

881

3881

1.49

25.65

1.1

43.73

78.08

au/ml

0.98

Gastrointestinal diseases

555

1665

1.68

25.53

1.1

65.14

67.65

au/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

859

3862

1.49

25.00

1.1

43.73

78.08

au/ml

0.98

Sleep apnoea

786

3296

1.51

24.37

1.1

67.29

70.62

au/ml

—

Intestinal infectious diseases

814

4109

1.48

23.53

1.1

39.00

74.65

au/ml

—

Giant cell arteritis with polymyalgia rheumatica

5.09

23.12

1.1

—

Other diseases of upper respiratory tract

893

3187

1.46

23.08

1.1

39.59

81.47

au/ml

1.39

Other and unspecified dermatitis

455

2753

1.66

23.02

1.1

47.19

70.08

au/ml

—

Temporal arteritis

101

4.99

22.60

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

619

3602

1.54

22.47

1.1

43.60

70.15

au/ml

—

Use of rivastigmine

108

384

2.83

22.13

1.1

—

55.88

—

Acute sinusitis

482

2717

1.62

21.82

1.1

50.57

82.56

au/ml

—

Undetermined asthma

117

439

2.69

21.76

1.1

—

88.43

—

Use of hypnotics and sedatives

888

3529

1.44

21.69

1.1

14.31

77.35

au/ml

—

Undetermined asthma, excluding more controls

117

440

2.69

21.66

1.1

—

73.36

—

Complications of surgical and medical care, not elsewhere classified

830

3828

1.45

21.53

1.1

55.84

71.04

au/ml

—

Non-selective monoamine reuptake inhibitors

270

1373

1.90

21.47

1.1

—

69.27

—

Benign neoplasm of meninges

105

376

2.84

21.47

1.1

—

74.17

—

Disorders of optic nerve, not elsewhere classified

5.89

21.35

1.0

1.1

—

Other shoulder lesions

102

362

2.86

21.20

1.1

—

97.52

—

Spinal stenosis

338

1401

1.79

21.17

1.1

49.42

81.83

au/ml

—

Arthropathies

789

2713

1.48

21.05

1.1

52.28

71.17

au/ml

—

Voice disturbances

235

1202

1.97

21.01

1.1

—

68.15

—

Dermatitis and eczema

940

3941

1.42

20.93

1.1

52.94

72.69

au/ml

0.40

Meningitis, viral

22.30

20.82

1.4

1.1

—

Giant cell arteritis

122

4.37

20.49

1.1

—

Use of dimethyl fumarate

8.57

20.32

1.0

1.1

—

Sleep disorders

777

3700

1.45

20.30

1.1

87.57

67.91

au/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

849

3818

1.43

20.29

1.1

34.86

74.45

au/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

801

3767

1.44

20.28

1.1

87.57

70.36

au/ml

—

Disorders of other endocrine glands

388

2294

1.67

20.23

1.1

107.75

59.54

au/ml

—

Benign neoplasm: Cerebral meninges

340

2.87

20.07

1.1

—

74.17

—

All kidney diseases

824

3880

1.43

19.61

1.1

67.25

70.08

au/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

623

2516

1.51

19.47

1.1

59.69

77.23

au/ml

—

Other and unspecified paralytic syndromes

6.78

19.39

1.1

1.0

—

Encephalopathy

8.38

19.38

1.2

1.0

—

Nonorganic sleeping disorders

230

1203

1.93

19.33

1.1

—

61.57

—

Myasthenia gravis

6.16

18.87

1.2

1.1

—

Dentofacial anomalies [including malocclusion]

640

3405

1.48

18.71

1.1

78.80

75.08

au/ml

—

Asthma, including avohilmo

980

3917

1.38

18.70

1.1

41.03

72.78

au/ml

—

Sleep apnoea, including avohilmo

805

3429

1.42

18.62

1.1

49.35

72.74

au/ml

0.53

Zoster [herpes zoster], including avohilmo

397

2367

1.63

18.51

1.1

114.14

63.20

au/ml

—

Insomnia

758

3704

1.43

18.30

1.1

87.57

67.91

au/ml

—

Falls/tendency to fall

885

3172

1.40

18.08

1.1

54.03

79.33

au/ml

—

Intestinal infectious diseases, including avohilmo, including avohilmo

933

3765

1.38

18.05

1.1

39.00

74.45

au/ml

—

Pure hypercholesterolaemia

551

2308

1.52

17.99

1.1

67.60

73.38

au/ml

—

Chronic lower respiratory diseases

1004

3874

1.37

17.95

1.1

34.43

73.76

au/ml

—

Optic atrophy

5.63

17.76

1.1

—

Optic atrophy, wide definition

5.62

17.75

1.1

—

Other viral diseases, not elsewhere classified

187

937

2.01

17.68

1.1

—

62.34

—

Memory loss

271

2.96

17.54

1.1

—

21.14

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

6.31

17.00

1.2

1.1

—

Urinary track infection

508

1656

1.54

16.88

1.1

—

88.75

—

Nystagmus and other irregular eye movements

5.92

16.49

1.1

—

Disorders of muscles

383

2.56

16.46

1.1

—

97.52

—

Diabetes insipidus

7.19

16.35

1.1

1.0

—

Personality disorders

269

1560

1.74

16.22

1.1

—

75.77

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

383

2.54

15.99

1.1

—

49.20

—

Asthma (diagnoses ohter than nonallergic)

714

4128

1.40

15.93

1.1

37.83

74.04

au/ml

—

Other symptoms and signs involving general sensations and perceptions

111

4.04

15.80

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

450

2977

1.52

15.76

1.1

49.28

67.36

au/ml

—

Injuries to the wrist and hand

836

4063

1.37

15.65

1.1

86.00

66.50

au/ml

—

Circumscribed brain atrophy

5.52

15.51

1.1

—

Brain glioblastoma

5.85

15.23

1.3

1.1

—

Complications of procedures, not elsewhere classified

642

3673

1.41

15.03

1.1

55.84

71.04

au/ml

—

Bleeding

610

3002

1.43

14.93

1.1

53.08

74.17

au/ml

—

Brain glioblastoma, helper endpoint

5.73

14.92

1.3

1.1

—

Polyarthropathies

524

2299

1.47

14.61

1.1

110.60

73.78

au/ml

—

Persistent mood disorders

162

839

1.95

14.16

1.1

—

79.79

—

Renal tubulo-interstitial diseases

679

3602

1.38

14.03

1.1

111.90

66.80

au/ml

—

Rheumatism, unspecified

107

478

2.26

13.87

1.1

—

78.01

—

Injuries to the knee and lower leg

952

3902

1.32

13.80

1.1

93.90

63.45

au/ml

—

Specific personality disorders

230

1341

1.73

13.70

1.1

—

64.33

—

Dental pulpitis, including avohilmo

778

3693

1.35

13.60

1.1

85.24

70.94

au/ml

—

Disorders of synovium and tendon

401

2261

1.51

13.46

1.1

94.07

70.40

au/ml

—

Other disorders of ear

696

3291

1.37

13.23

1.1

58.40

75.53

au/ml

—

Acute bronchitis

315

1967

1.58

13.18

1.1

—

68.98

—

Intracerebral haemorrhage

352

2.43

13.10

1.0

1.1

—

47.99

—

Heartburn

101

454

2.25

12.94

1.1

—

84.52

—

Phobic anxiety disorders

136

684

2.00

12.91

1.1

—

72.73

—

Psychotic depression

182

3.00

12.48

1.1

—

109.72

—

Emotionally unstable personality disorder

137

702

1.97

12.47

1.1

—

71.07

—

Hereditary ataxia

5.55

12.41

1.0

1.1

—

Substance abuse

454

2931

1.44

12.38

1.1

—

57.14

—

Cauda equina syndrome

5.31

12.33

1.1

—

Retrobulbar neuritis in diseases classified elsewhere

14.36

12.07

1.0

1.2

—

Hypothyroidism, other/unspecified

684

3334

1.35

12.05

1.1

67.40

68.58

au/ml

—

Chronic diseases of tonsils and adenoids

626

2889

1.37

11.93

1.1

22.33

93.42

au/ml

—

Diseases of the skin and subcutaneous tissue

770

2900

1.34

11.91

1.1

57.88

73.40

au/ml

0.30

Mental and behavioural disorders due to psychoactive substance use

464

2987

1.43

11.90

1.1

—

57.14

—

Non-allergic asthma (mode)

130

658

1.97

11.88

1.1

—

93.35

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

707

3460

1.34

11.84

1.1

67.40

68.02

au/ml

—

Non-allergic asthma (mode), excluding more controls

130

660

1.96

11.78

1.1

—

81.79

—

Viral infections of central nervous system, not elsewhere classified/unspecified

5.91

11.58

1.2

1.1

—

Mycoses, including avohilmo

732

4214

1.33

11.57

1.1

48.43

73.26

au/ml

—

Benign neoplasm: Brain, supratentorial

4.80

11.51

1.1

—

Other and unspecified drugs and medicaments

369

2.31

11.45

1.1

—

49.20

—

Other symptoms and signs involving the circulatory and respiratory systems

248

2.61

11.44

1.1

—

20.95

—

Other/unspecified disorders of vestibular function

139

3.22

11.41

1.1

—

All influenza (not pneumonia)

126

652

1.95

11.17

1.1

—

35.55

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

146

3.13

11.16

1.1

—

21.90

—

Disorders of the thyroid gland

723

3553

1.32

11.03

1.1

63.83

68.80

au/ml

—

Other disorders of peripheral nervous system

11.35

10.99

1.2

1.1

—

Alcohol use disorder, Swedish definition

407

2583

1.44

10.87

1.1

—

58.38

—

Unspecified visual impairment (binocular)

5.27

10.86

1.1

—

Other disorders of optic disc

4.72

10.82

1.1

—

Conjunctivitis (acute, non atopic)

241

1512

1.60

10.71

1.1

36.28

76.41

au/ml

—

Early onset COPD, excluding more controls

124

647

1.93

10.69

1.2

1.1

—

79.78

—

Abnormal findings on examination of blood, without diagnosis

325

1975

1.49

10.63

1.1

72.25

64.40

au/ml

—

Carpal tunnel syndrome

418

2556

1.42

10.47

1.1

91.28

88.11

au/ml

—

Use of riluzole

14.55

10.45

1.0

1.2

—

Infections of the skin and subcutaneous tissue

468

3327

1.39

10.41

1.1

32.50

70.71

au/ml

—

Use of amantadine

4.40

10.39

1.0

1.1

—

Benign neoplasms

769

3218

1.30

10.27

1.1

46.11

68.16

au/ml

—

Disorders of conjunctiva

667

3930

1.32

10.24

1.1

69.05

72.50

au/ml

—

Chronic apical periodontitis

868

3809

1.28

10.18

1.1

54.33

74.87

au/ml

0.58

Other disorders of skin and subcutaneous tissue

523

3250

1.36

10.14

1.1

36.91

78.67

au/ml

—

Conjunctivitis

616

3739

1.33

10.12

1.1

69.05

74.89

au/ml

—

Dislocation, sprain and strain of joints and ligaments at neck level

151

856

1.78

10.10

1.1

—

73.78

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

223

1218

1.61

10.00

1.0

1.1

—

22.14

—

Hyperhidrosis

3.61

9.95

1.1

—

Urticaria

256

1667

1.54

9.90

1.1

—

53.09

—

Inflammatory disease of uterus

132

725

1.84

9.82

1.0

1.1

—

89.57

—

Abnormal findings in cerebrospinal fluid

11.03

9.70

1.2

—

Unspecified/other endometriosis

101

501

2.00

9.60

1.1

—

57.68

—

Reimbursement for rheumatic diseases

414

2958

1.40

9.56

1.1

80.20

67.19

au/ml

—

451

2854

1.38

9.51

1.1

—

57.21

—

Use of fingolimod

5.37

9.47

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

762

3753

1.29

9.46

1.1

52.70

71.48

au/ml

—

429

2769

1.39

9.45

1.1

—

57.21

—

Reactive arthropathies

348

2.21

9.45

1.1

—

74.40

—

Tetraplegia

11.23

9.42

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

325

2228

1.45

9.35

1.1

—

63.50

—

Mental and behavioural disorders due to alcohol

378

2564

1.41

9.19

1.1

—

58.04

—

Alcohol abuse, main dg, excluding more controls

110

584

1.90

9.12

1.1

—

76.48

—

Disorders of choroid and retina

547

2885

1.33

8.91

1.1

73.34

70.66

au/ml

—

Other and unspecified disorders of binocular movement

10.68

8.68

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

785

3201

1.27

8.64

1.1

57.49

65.73

au/ml

—

Pain associated with micturition

492

1.95

8.53

1.1

—

53.19

—

Pain and other conditions associated with female genital organs and menstrual cycle

196

1035

1.59

8.52

1.1

—

67.84

—

Injuries to the shoulder and upper arm

625

3747

1.29

8.28

1.1

49.66

74.45

au/ml

—

Superficial injury of lower leg

208

1350

1.55

8.27

1.1

—

64.71

—

Other enthesopathies

208

1353

1.54

8.17

1.1

125.40

84.61

au/ml

—

Bruxism

3.55

8.16

1.1

—

Obstructive hydrocephalus

4.23

8.06

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

397

2461

1.37

8.03

1.1

83.65

69.24

au/ml

—

Hypersomnia

4.16

7.87

1.2

1.1

—

Hyperlipidaemia, other/unspecified

233

1405

1.50

7.81

1.1

45.00

81.02

au/ml

—

Other symptoms and signs involving the urinary system

392

2.01

7.68

1.1

—

24.74

—

Alcohol use disorder, ICD-based

294

2076

1.42

7.68

1.1

—

67.65

—

Diseases of male genital organs

347

1246

1.41

7.63

1.1

44.17

54.67

au/ml

—

Degeneration of the brain due to alcohol

3.66

7.62

1.1

—

Cerebral arteritis

14.93

7.60

1.8

1.0

—

Iridocyclitis in diseases classified elsewhere

3.56

7.60

1.3

1.1

—

Sensorineural hearing loss

480

2423

1.32

7.59

1.1

67.57

71.75

au/ml

—

Other complications of surgical and medical care, not elsewhere classified

415

1.97

7.56

1.1

—

43.22

—

Conductive and sensorineural hearing loss

517

2629

1.31

7.53

1.1

67.57

74.76

au/ml

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

125

391

1.76

7.44

1.1

—

100.17

—

Neuralgic amyotrophy

13.91

7.37

1.2

1.1

—

Benign neoplasm: Colon

330

2245

1.38

7.32

1.1

83.65

67.65

au/ml

—

Early lumbar disc prolapse, operated

462

1.90

7.32

1.0

1.1

—

88.77

—

Moderate visual impairment, binocular

3.43

7.27

1.2

1.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

248

2.24

7.26

1.1

1.0

—

Cerebral amyloid angiopathy

9.35

7.18

1.1

—

Complications of genitourinary prosthetic devices, implants and grafts

3.17

7.17

1.1

—

Persons encountering health services for specific procedures, not carried out

389

1.97

7.15

1.1

—

43.22

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.31

7.07

1.2

1.1

—

Chronic gastritis

159

1008

1.58

7.07

1.1

—

74.18

—

Asthma/COPD (KELA code 203)

720

3871

1.24

7.07

1.1

43.40

73.76

au/ml

—

Secondary parkinsonism+Parkinsonism in other disease

3.34

6.99

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

219

1493

1.47

6.96

1.1

29.40

80.90

au/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

152

651

1.62

6.94

1.0

1.1

—

75.17

—

Other and unspecified urticaria

159

1016

1.57

6.87

1.1

—

67.73

—

Diseases of pulp and periapical tissues and dental caries

436

1685

1.33

6.86

1.1

64.20

72.49

au/ml

—

Superficial injury of hip and thigh

105

603

1.75

6.85

1.1

—

40.99

—

Causalgia

3.86

6.85

1.2

1.1

—

Nonpyogenic thrombosis of intracranial venous system

5.85

6.85

1.4

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

562

2750

1.28

6.84

1.1

112.32

77.93

au/ml

—

Other cranial nerve disorders in other disorders

13.58

6.77

1.0

1.1

—

Mononeuritis multiplex

11.11

6.73

1.3

1.0

—

Secondary parkinsonism

3.26

6.72

1.1

—

Drug-induced systemic lupus erythematosus

8.18

6.71

1.1

—

Senile cataract

375

1696

1.35

6.67

1.1

66.52

74.68

au/ml

—

Transplanted organ and tissue status

422

1.89

6.58

1.1

—

21.55

—

Morphin

3.86

6.55

1.0

1.1

—

Hyperosmolality and hypernatraemia

5.43

6.51

1.1

1.0

—

Amyloidosis

3.44

6.45

1.0

1.1

—

Manic episode

107

2.85

6.45

1.0

1.1

—

Substance use, excluding alcohol

162

1056

1.54

6.44

1.1

—

82.03

—

Polycystic ovarian syndrome, consortium definition

544

2455

1.27

6.39

1.1

96.72

83.55

au/ml

—

Other congenital malformations of circulatory system

2.94

6.35

1.0

1.1

—

Disease of hard tissues of teeth, NOS

354

1372

1.35

6.34

1.1

32.96

72.29

au/ml

—

Missing teeth due to accident, extraction or parodontitis

403

2750

1.31

6.34

1.1

63.04

69.59

au/ml

—

Other or unspecified paralytic strabismus

7.32

6.30

1.3

1.1

—

Open wound of wrist and hand

338

2447

1.34

6.19

1.1

—

56.74

—

Emotional disorders starting during childhood or adolescence

249

2.13

6.18

1.1

1.0

—

Amenorrhoea

370

1.91

6.06

1.1

—

57.68

—

Dental caries, including avohilmo

481

1917

1.29

6.04

1.1

70.51

67.06

au/ml

—

Raynaud syndrome

442

1.83

6.04

1.1

—

49.20

—

L04AD Calcineurin inhibitors

515

1.76

6.03

1.1

—

65.29

—

Open wound of head

362

2584

1.32

5.99

1.1

33.26

75.02

au/ml

—

Diseases of oral cavity, salivary glands and jaws

361

1394

1.34

5.98

1.1

19.67

72.29

au/ml

—

Thiamine deficiency

6.72

5.96

1.0

1.1

—

Amblyopia ex anopsia

154

2.43

5.89

1.1

—

Vascular dementia (subcortical)

3.42

5.87

1.1

—

Other specified and unspecified strabismus

3.88

5.86

1.1

1.0

—

Misadventures to patients during surgical and medical care

103

617

1.68

5.86

1.1

—

72.74

—

Polyarteritis nodosa and related conditions

3.87

5.85

1.0

1.1

—

Eosinophilic disease (BM)

3.86

5.85

1.2

1.0

—

Other diseases of hard tissues of teeth

357

1391

1.33

5.79

1.1

49.77

72.29

au/ml

—

Secondary and unspecified malignant neoplasm of lymph nodes

320

1.95

5.77

1.1

—

25.21

—

Nonhereditary hypogammaglobulinemia

4.88

5.67

1.1

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.20

5.64

1.3

1.2

—

Disorders of brain, other and unspecified

5.18

5.63

1.0

—

Behavioural disorders, excluding more controls

3.14

5.61

1.2

1.1

—

Disorders of vitreous body and globe

316

2253

1.33

5.58

1.1

17.33

82.62

au/ml

—

Anaemia in chronic diseases classified elsewhere

3.04

5.56

1.1

—

Malnutrition

3.19

5.49

1.2

1.1

—

Aplastic and other anaemias

268

1808

1.36

5.48

1.1

—

68.78

—

Disorders of vitreous body

308

2209

1.33

5.45

1.1

17.33

82.62

au/ml

—

Narcolepsy and cataplexy

6.44

5.45

1.2

1.1

—

Other and unspecified anaemias

245

1674

1.38

5.45

1.1

—

68.78

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

577

1.67

5.42

1.1

—

65.29

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

289

1350

1.35

5.40

1.1

—

84.00

—

Sequelae of inflammatory diseases of the central nervous system

12.05

5.39

1.2

1.0

—

COPD (mode)

152

789

1.51

5.34

1.1

—

85.31

—

Mouth breathing

267

1978

1.35

5.33

1.1

—

63.60

—

Malignant immunoproliferative diseases

5.17

5.31

1.2

1.1

—

Other anaemias

246

1685

1.37

5.30

1.1

—

68.78

—

Agoraphobia

138

2.42

5.24

1.1

1.0

—

Neuromyelitis optica

9.08

5.19

1.0

1.3

—

Dental operations

379

1504

1.30

5.18

1.1

44.32

63.84

au/ml

—

Atopic dermatitis

471

3001

1.25

5.15

1.1

61.80

62.88

au/ml

—

Rheumatoid arthritis

196

1231

1.41

5.08

1.1

80.20

93.62

au/ml

—

Other diseases of arteries and capillaries

343

1.85

5.04

1.1

—

20.95

—

Atypical virus infections of central nervous system, including avohilmo

4.48

5.00

1.1

—

Other obstetric conditions, not elsewhere classified

292

1387

1.33

4.99

1.1

—

75.04

—

Conjunctivitis (acute, non atopic), including avohilmo

733

3703

1.20

4.96

1.1

36.17

72.48

au/ml

—

Somnolence

3.74

4.96

1.2

1.1

—

Amyloidosis, other/unspecified

3.39

4.91

1.1

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.04

4.88

1.4

1.1

—

Other abnormal immunological findings in serum

2.87

4.85

1.0

1.1

—

Vitamin D deficiency

2.79

4.81

1.0

1.1

—

Caries of dentine, including avohilmo

514

2124

1.24

4.81

1.1

70.51

66.61

au/ml

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.49

4.79

1.1

—

Intentional self-harm by unspecified means

3.48

4.78

1.3

1.1

—

Other and unspecified disorders of autonomic nervous system

6.47

4.69

1.2

1.1

—

Abnormal reflex

6.41

4.67

1.1

1.2

—

103

2.56

4.66

1.1

—

Other diseases of anus and rectum

183

1306

1.40

4.60

1.1

94.08

58.40

au/ml

—

Atypical virus infections of central nervous system

4.30

4.57

1.1

—

Urolithiasis

192

1391

1.38

4.53

1.1

49.22

70.91

au/ml

—

Convergence insufficiency and excess

3.22

4.52

1.4

1.1

—

Mild or no visual impairment, binocular

6.08

4.51

1.2

1.1

—

Care involving dialysis

284

1.88

4.50

1.1

—

21.68

—

Disorders in reading

2.82

4.48

1.0

1.1

—

Fentanyl

284

1.87

4.46

1.0

1.1

—

23.46

—

Injury of muscle and tendon at shoulder and upper arm level

218

1618

1.35

4.43

1.1

80.60

78.27

au/ml

—

GI-bleeding

176

1262

1.40

4.42

1.1

—

68.60

—

Hyperplasia of prostate

203

828

1.38

4.40

1.1

14.74

57.21

au/ml

—

Endometriosis of pelvic peritoneum

127

780

1.49

4.36

1.1

—

67.84

—

Secondary uncertain malignant neoplasm

481

1.65

4.33

1.1

—

25.21

—

Procreative management

260

1633

1.32

4.29

1.1

—

80.48

—

Diseases of peritoneum

385

1.73

4.26

1.1

—

23.46

—

Personal history of risk-factors, not elsewhere classified

3.20

4.23

1.1

1.0

—

Marginal zone B-cell lymphoma, including Hilmo

3.20

4.23

1.2

1.1

—

Fracture of lumbar spine and pelvis

124

839

1.48

4.23

1.1

—

66.72

—

Muscle wasting and atrophy, not elsewhere classified

7.15

4.20

1.0

1.1

—

Hypertensive encephalopathy

8.40

4.12

1.4

1.0

—

Other diseases of the digestive system

175

1271

1.38

4.11

1.1

—

72.45

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

148

2.19

4.10

1.0

1.1

—

Secondary thrombocytopenia

3.26

4.09

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

173

2.06

4.05

1.1

—

Hereditary motor and sensory neuropathy

4.57

3.97

1.0

1.1

—

Benign neoplasm: Ascending colon

524

1.59

3.97

1.1

—

25.21

—

Other specified/unspecified necrotizing vasculopathies

3.32

3.93

1.1

1.0

—

Other and unspecified epidermal thickening

100

2.43

3.91

1.0

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

7.60

3.91

1.0

—

Lack of expected normal physiological development

3.08

3.90

1.0

1.1

—

Vascular dementia (other)

7.45

3.88

1.1

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

396

1.68

3.88

1.1

—

23.46

—

Drug-induced osteoporosis with pathological fracture

3.02

3.87

1.4

1.0

—

Other congenital malformations of respiratory system

9.56

3.87

1.1

1.0

—

Gastroduodenal ulcer

132

922

1.43

3.84

1.1

—

78.17

—

Symptoms and signs involving emotional state

101

2.40

3.83

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

228

1745

1.31

3.82

1.1

80.20

58.88

au/ml

—

Behçet disease

12.57

3.80

1.0

1.4

—

Haemorrhage, not elsewhere classified

2.55

3.80

1.0

1.1

—

Malignant neoplasm of digestive organs

114

1260

0.69

3.78

1.1

—

53.70

—

Severe visual impairment, monocular

3.68

3.73

1.4

1.1

—

Toxoplasmosis, including avohilmo

5.19

3.73

1.0

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

588

1.54

3.73

1.1

—

41.22

—

Infective dermatitis

447

1.62

3.72

1.0

1.1

—

34.94

—

Eosinophilia

2.84

3.71

1.2

1.1

—

Other disorders of binocular vision

3.17

3.67

1.1

—

Other erythematous conditions

142

2.14

3.66

1.0

1.1

—

Corticotropin deficiency

4.11

3.63

1.1

1.0

—

Other and unspecified erythematous conditions

123

2.22

3.62

1.0

1.1

—

Brain astrocytoma, including Hilmo

5.00

3.62

1.1

1.2

—

Brain astrocytoma

5.00

3.62

1.1

1.2

—

Fall on same level involving ice and snow

384

3146

1.22

3.61

1.1

53.92

67.16

au/ml

—

Appendicitis, broad definition

521

3937

1.19

3.61

1.1

29.86

75.54

au/ml

—

Caries of enamel

702

3950

1.16

3.60

1.1

44.14

77.71

au/ml

—

Diverticular disease of intestine

422

2160

1.22

3.60

1.1

102.15

63.74

au/ml

—

Other and unspecified disorders of vitreous body

240

1823

1.29

3.60

1.1

17.33

86.46

au/ml

—

Moderate visual impairment, monocular

5.51

3.56

1.3

1.1

—

Cerebral oedema

10.69

3.56

1.3

1.0

—

Vitreous haemorrhage

406

1.64

3.56

1.0

1.1

—

52.06

—

Complications following infusion, transfusion and therapeutic injection

3.09

3.55

1.0

1.1

—

Implicit parasitic Sepsis, including avohilmo

5.46

3.54

1.0

1.2

—

Superficial injury of thorax

662

1.49

3.50

1.1

—

53.19

—

Helminthiases, including avohilmo

179

1.97

3.49

1.0

1.1

—

Bitten or struck by other mammals

606

1.51

3.49

1.0

1.1

—

49.20

—

Diseases of appendix

523

3952

1.18

3.49

1.1

29.86

75.54

au/ml

—

Brain astrocytoma, helper endpoint

4.77

3.49

1.1

1.2

—

Other abnormal products of conception

256

1313

1.28

3.48

1.1

—

74.25

—

Other inflammation of eyelid

615

1.50

3.46

1.1

—

56.96

—

Gingivitis and periodontal diseases

682

3027

1.16

3.43

1.1

41.50

76.17

au/ml

—

Acute appendicitis

491

3840

1.19

3.42

1.1

29.86

75.54

au/ml

—

Chronic inflammatory disorders of orbit

7.41

3.42

1.0

—

Disorders of other and unspecified cranial nerves

5.18

3.41

1.2

1.1

—

Viral and other specified intestinal infections, including avohilmo

214

1589

1.30

3.41

1.1

—

49.93

—

Anomalies of pupillary function

2.47

3.40

1.1

—

Other and unspecified neuropathies

7.26

3.40

1.0

1.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.88

3.38

1.1

—

Necrosis of pulp, including avohilmo

425

3501

1.20

3.38

1.1

85.14

69.58

au/ml

—

Intercostal neuropathy

5.84

3.36

1.1

—

Vascular dementia (multiple infarctions)

5.76

3.34

1.4

1.0

—

Disorders of magnesium metabolism

4.04

3.32

1.1

—

Dermatitis due to substances taken internally

211

1.86

3.31

1.1

—

Malignant neoplasm of digestive organs, including Hilmo

135

1360

0.73

3.31

1.1

—

49.97

—

Acute disseminated encephalitis/encephalomyelitis

6.96

3.27

1.1

1.0

—

Epidural haemorrhage

8.68

3.27

1.2

1.0

—

Epileptic seizures related to drugs

5.64

3.25

1.1

—

Lagophthalmos

3.40

3.25

1.3

1.1

—

Collagenous colitis

393

1.61

3.24

1.0

1.1

—

49.20

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.41

3.24

1.4

1.1

—

Marginal zone B-cell lymphoma

3.61

3.22

1.2

1.1

—

Hypersplenism

6.59

3.22

1.0

1.1

—

Gastric ulcer

617

1.48

3.22

1.1

—

58.55

—

Insulin, combination of fast acting with intermediate-acting or long-acting

379

2847

1.21

3.21

1.1

72.24

65.48

au/ml

—

Early onset COPD

124

891

1.40

3.21

1.2

1.1

—

80.31

—

Achilles tendinitis

387

1.61

3.19

1.1

—

96.68

—

Horner syndrome

2.78

3.18

1.1

—

Motor disorders, excluding more controls

3.34

3.17

1.0

1.2

—

Ischemic heart diseases

526

2661

1.18

3.16

1.1

85.83

72.41

au/ml

—

Other and unspecified myoneural disorders

5.23

3.10

1.0

1.1

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.23

3.08

1.2

1.1

—

Other factor of the environment

3.23

3.08

1.0

1.1

—

Pruritus

495

1.52

3.05

1.1

—

108.00

—

Drug-induced osteoporosis

2.94

3.04

1.0

1.1

—

Other and unspecified vaccines and biological substances

3.66

3.03

1.1

—

Viral conjunctivitis

100

2.23

3.01

1.0

1.1

—

Other epidermal thickening

168

1.92

3.00

1.1

—

Excessive attrition of teeth

439

3677

1.18

3.00

1.1

71.80

69.85

au/ml

—

Ehlers-Danlos syndrome, including avohilmo

2.68

2.99

1.1

—

Myopia

100

704

1.43

2.95

1.0

1.1

—

49.20

—

Alcohol abuse, main dg

110

788

1.40

2.94

1.1

—

59.81

—

Obesity, other/unspecified

242

1937

1.25

2.94

1.0

1.1

—

62.51

—

Chronic myeloproliferative disease

2.87

2.94

1.1

—

Previous suicide attempt

2.75

2.91

1.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

4.19

2.90

1.2

1.1

—

Injury of nerves at hip and thigh level

5.60

2.90

1.0

1.3

—

Cerebral atherosclerosis

3.48

2.90

1.2

1.1

—

Colour vision deficiencies

5.55

2.90

1.0

—

Severe visual impairment, binocular

5.53

2.89

1.0

1.2

—

Endometriosis ASRM stages 1,2

128

944

1.36

2.88

1.1

—

84.13

—

Cardiac murmurs and other cardiac sounds

393

1.57

2.88

1.1

—

43.22

—

Gonarthrosis

378

1779

1.20

2.87

1.1

28.28

90.71

au/ml

—

Mental and behavioural disorders due to tobacco

400

1.56

2.82

1.1

—

50.08

—

Malignant melanoma of skin, including Hilmo

537

1.48

2.81

1.1

—

53.45

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.66

2.81

1.3

1.0

—

Superficial injury of ankle and foot

695

1.42

2.80

1.1

—

74.90

—

Smoking dependency

401

1.56

2.79

1.1

—

50.08

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.99

2.79

1.0

—

Tic and related disorders

3.11

2.78

1.2

1.1

—

Other or unspecified common variable immunodeficiency

5.23

2.77

1.0

1.1

—

Injury of blood vessels at lower leg level

5.16

2.75

1.0

1.1

—

Syndrome of inappropriate secretion of antidiuretic hormone

5.13

2.75

1.3

1.0

—

Erythema intertrigo

2.22

2.75

1.1

—

Other forms of systemic lupus erythematosus

3.08

2.72

1.2

1.1

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

6.20

2.72

1.0

1.2

—

Polyarteritis nodosa

4.31

2.70

1.0

1.2

—

Synovial hypertrophy, not elsewhere classified

4.28

2.69

1.0

1.2

—

Acute alcohol intoxication, ICD10

136

1025

1.33

2.68

1.1

—

63.28

—

Spinal osteochondrosis

3.20

2.66

1.0

1.2

—

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

4.78

2.62

1.0

—

Drug-induced tremor

3.69

2.60

1.0

1.2

—

Other diseases of pancreas

337

1.58

2.59

1.1

—

49.36

—

Toxoplasmosis

4.11

2.59

1.0

1.2

—

Alcohol induced polyneuropathy

3.66

2.59

1.2

1.0

—

Salpingitis and oophoritis

106

774

1.37

2.58

1.1

—

88.43

—

Congenital malformations of the circulatory system

100

702

1.39

2.57

1.1

—

43.00

—

Late syphilis

2.77

2.56

1.3

1.0

—

Insulin medication

379

2666

1.18

2.55

1.1

72.24

64.12

au/ml

—

Superficial injury of shoulder and upper arm

541

1.45

2.54

1.1

—

75.12

—

Nonsuppurative otitis media, including avohilmo

236

1656

1.23

2.54

1.1

—

53.82

—

Early lumbar disc prolapse operation

620

1.41

2.46

1.0

1.1

—

51.91

—

Protein-energy malnutrition of moderate and mild degree

3.18

2.45

1.3

1.0

—

Injuries to unspecified part of trunk, limb or body region

439

1.49

2.44

1.0

1.1

—

23.46

—

Nonsuppurative otitis media

171

1167

1.27

2.43

1.0

1.1

—

33.91

—

Injury of nerves at lower leg level

2.95

2.43

1.0

1.1

—

Labyrinthitis

5.18

2.43

1.5

1.1

—

Acrodermatitis continua

6.59

2.41

1.0

1.3

—

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

6.52

2.40

1.0

1.3

—

Sleepwalking [somnambulism]

4.30

2.39

1.3

1.1

—

Deficiency of other B group vitamins

2.23

2.38

1.1

—

Disorders of male genital organs in diseases classified elsewhere

3.72

2.38

1.4

1.1

—

Late syphilis, including avohilmo

2.45

2.38

1.3

1.1

—

Implicit parasitic Sepsis

4.23

2.38

1.0

1.2

—

Scleritis

2.54

2.37

1.0

1.1

—

4.19

2.37

1.3

1.0

—

Other bacterial agents as the cause of diseases classified to other chapters

3.08

2.37

1.2

1.1

—

Other abortion

2.88

2.36

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

441

2184

1.16

2.36

1.1

54.06

84.28

au/ml

—

Lifestyle-related condition

2.87

2.36

1.0

1.1

—

Retinal detachment with retinal break

484

1.45

2.35

1.1

—

38.76

—

Common variable immunodeficiency

3.30

2.33

1.2

1.1

—

Torticollis

2.34

2.33

1.2

1.1

—

Muscular dystrophy

3.01

2.30

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

130

998

1.31

2.30

1.1

—

86.22

—

Burns classified according to extent of body surface involved

2.99

2.29

1.1

—

Benign neoplasm: Brain, unspecified

3.57

2.29

1.1

1.2

—

Peritonsillar abscess

140

1087

1.29

2.28

1.1

—

77.78

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

4.00

2.27

1.3

1.1

—

Use of disulfiram, acamprosate or naltrexone

422

1.48

2.27

1.0

1.1

—

44.90

—

Other diseases of oesophagus

333

1.54

2.26

1.1

—

24.46

—

Anisometropia and aniseikonia

120

1.93

2.26

1.1

—

Perforation of tympanic membrane

431

1.47

2.25

1.1

—

23.46

—

Familial benign pemphigus (Hailey-Hailey disease)

5.82

2.24

1.0

1.2

—

Toxic effect of organic solvents

5.70

2.23

1.0

1.2

—

Tracheo-bronchomalasia

5.67

2.22

1.2

—

Viral pneumonia (known virus, not influenza)

2.06

2.22

1.1

—

Melanocytic naevi of upper limb, including shoulder

100

2.02

2.22

1.0

1.1

—

Congenital malformations of spine and bony thorax

3.42

2.20

1.3

1.1

—

Increased muscle tone

3.40

2.19

1.1

—

Viral and other specified intestinal infections

150

1153

1.27

2.19

1.1

—

29.67

—

Other arthrosis

302

1705

1.19

2.18

1.1

53.17

90.71

au/ml

—

Palmar fascial fibromatosis [Dupuytren]

467

1.44

2.17

1.1

—

72.33

—

Acute alcohol intoxication

153

1210

1.27

2.17

1.1

—

68.85

—

Radial styloid tenosynovitis [de Quervain]

219

1.65

2.15

1.1

—

97.52

—

Kyphosis

2.65

2.15

1.0

1.1

—

Injury of eye and orbit

714

1.35

2.14

1.0

1.1

—

72.39

—

Iron deficiency anaemia secondary to blood loss (chronic)

604

1.38

2.12

1.1

—

68.54

—

Communicating hydrocephalus

2.23

2.12

1.1

1.0

—

Nail dystrophy

3.27

2.11

1.0

1.1

—

Oral lichen planus, including avohilmo , including avohilmo

299

1.55

2.11

1.1

—

60.60

—

Pregnancy with abortive outcome

437

1976

1.15

2.11

1.1

—

80.57

—

Ehlers-Danlos syndrome

2.60

2.09

1.1

—

Hereditary hypogammaglobulinemia

5.15

2.09

1.0

—

Idiopathic peripheral autonomic neuropathy

5.14

2.09

1.2

1.1

—

Cholecystectomy

430

3185

1.15

2.08

1.1

64.53

77.66

au/ml

—

Flat foot [pes planus] (acquired)

373

1.48

2.07

1.1

—

79.17

—

Malignant melanoma, including Hilmo

658

1.36

2.07

1.1

—

57.26

—

Drug-induced headache, not elsewhere classified

3.58

2.07

1.3

1.1

—

Frontotemporal dementia, wide, incl. Pick's disease

3.57

2.07

1.0

1.1

—

Explicit fungal Sepsis

3.57

2.07

1.0

1.2

—

Explicit fungal Sepsis, including avohilmo

3.56

2.07

1.0

1.2

—

Glaucoma

291

2093

1.18

2.07

1.1

83.81

61.67

au/ml

—

Other specified and unspecified disorders of choroid

4.12

2.06

1.0

—

Beningn neoplasm: Meninges, unspecified

2.43

2.03

1.2

1.1

—

Infection of intervertebral disc (pyogenic)

2.53

2.02

1.3

1.0

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.25

2.02

1.1

1.0

—

Seborrhoeic dermatitis

400

1.46

2.02

1.1

—

34.94

—

Symptoms and signs involving appearance and behaviour

2.86

2.01

1.0

1.1

—

Other misadventures during surgical and medical care

2.02

2.01

1.1

—

Vascular dementia (mixed)

2.83

2.00

1.2

1.1

—

Disorders of tooth development and eruption

108

670

1.31

2.00

1.1

—

93.72

—

Pyoderma

2.17

1.99

1.1

—

Other or unspecified ileus, impaction or obstruction

680

1.34

1.98

1.0

1.1

—

62.35

—

Hydrocephalus in other diseases

3.41

1.98

1.0

—

Effects of heat and light

3.39

1.97

1.0

1.1

—

Malignant neoplasm of rectum, including Hilmo

438

0.59

1.96

1.1

—

25.44

—

Unspecified threat to breathing

2.60

1.95

1.0

1.1

—

Arteriovenous malformation of peripheral vessels

3.83

1.95

1.0

1.2

—

Other eating disorders

265

1.56

1.94

1.0

1.1

—

Benign neoplasm: Prostate

3.82

1.94

1.2

1.1

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.59

1.94

1.0

1.2

—

Trigger finger

563

1.37

1.94

1.1

94.07

100.94

au/ml

—

Specific developmental disorder of motor function

2.28

1.93

1.0

1.1

—

Alcohol dependence

153

1230

1.25

1.93

1.1

—

68.85

—

Other local infections of skin and subcutaneous tissue

446

1.42

1.92

1.1

—

43.35

—

Sequelae of injuries of lower limb

430

1.42

1.91

1.0

1.1

—

43.00

—

Endometriosis diagnosis and infertility diagnosis occurring together

608

1.35

1.91

1.1

—

103.23

—

Secondary polycythaemia

2.02

1.91

1.0

1.1

—

Fall involving bed

1.97

1.90

1.0

1.1

—

Benign neoplasm: Tonsil

0.00

1.90

0.0

1.1

—

Other and unspecified disorders of adult personality and behaviour

3.25

1.89

1.0

1.1

—

Hyperkinetic disorders (excl. ADHD)

2.01

1.89

1.1

1.0

—

Other maternal disorders predominantly related to pregnancy

391

2131

1.15

1.89

1.1

162.00

65.54

au/ml

—

Percutaneous Coronary Intervention

471

2526

1.13

1.88

1.1

57.03

66.09

au/ml

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

2.91

1.87

1.1

—

Hypertrophy of (infrapatellar) fat pad

2.89

1.87

1.1

—

Malignant neoplasm of pancreas, including Hilmo

278

0.50

1.86

1.0

1.1

—

26.86

—

Other and unspecified nail disorders

1.99

1.86

1.2

1.1

—

Calcific tendinitis of shoulder

214

1.60

1.82

1.2

1.1

—

97.52

—

Endometriosis of rectovaginal septum and vagina

335

1.47

1.82

1.0

1.1

—

61.18

—

Superficial frostbite

3.10

1.81

1.0

1.2

—

Aspergillosis

3.09

1.81

1.0

—

Flatulence and related conditions

2.79

1.80

1.0

1.1

—

Mixed connective tissue disease

2.11

1.77

1.1

—

Malignant neoplasm of pancreas

219

0.45

1.76

1.0

1.1

—

26.86

—

Frontotemporal dementia

3.40

1.76

1.0

1.1

—

Tarsal tunnel syndrome

2.54

1.75

1.1

—

Personal history of medical treatment

2.53

1.75

1.0

—

Malignant melanoma

583

1.34

1.74

1.1

—

57.26

—

Congenital malformations of spine and bony thorax, including avohilmo

2.72

1.74

1.3

1.1

—

Coronary revascularization (ANGIO or CABG)

469

2527

1.13

1.74

1.1

57.02

66.09

au/ml

—

Benign neoplasm: Spinal meninges

2.70

1.73

1.6

1.0

—

Syndactyly, including avohilmo

3.95

1.73

1.0

1.2

—

Other and unspecified syphilis, including avohilmo

3.94

1.73

1.0

1.1

—

Complications of anaesthesia during labour and delivery

3.94

1.73

1.0

1.2

—

Dislocation of lens

2.69

1.73

1.3

1.2

—

Enteritis due to Yersinia enterocolitica

3.91

1.72

1.2

—

Lateral epicondylitis

516

1.36

1.72

1.1

—

100.94

—

Diabetes, varying definitions

702

3697

1.10

1.68

1.1

50.24

69.54

au/ml

—

Injury of muscle and tendon at hip and thigh level

467

1.38

1.68

1.1

—

66.10

—

ILD, hospital admissions 3, with pneumonia sepsis

251

1.52

1.67

1.1

—

27.60

—

Malignant neoplasm of breast, including Hilmo

178

1372

0.83

1.67

1.1

—

86.61

—

Primary adrenocortical insufficiency

2.54

1.67

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

178

1372

0.83

1.67

1.1

—

86.61

—

Disorders of gallbladder, biliary tract and pancreas

633

3564

1.11

1.66

1.1

57.80

75.45

au/ml

—

Female infertility, cervical, vaginal, other or unspecified origin

187

994

1.21

1.66

1.1

—

67.84

—

Acute gastritis

268

1.50

1.66

1.1

—

43.22

—

Aspergillosis, including avohilmo

2.84

1.66

1.0

1.1

—

Primary hyperparathyroidism

409

1.40

1.66

1.1

—

74.17

—

Abdominal aortic aneurysm (AAA)

238

0.50

1.65

1.0

1.1

—

56.65

—

Hernia

602

3613

1.11

1.65

1.1

64.50

72.04

au/ml

—

Tic disorders

2.27

1.64

1.2

1.1

—

Major coronary heart disease event

497

2657

1.12

1.64

1.1

60.67

73.64

au/ml

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

354

0.59

1.64

1.1

—

25.21

—

Hypertrichosis

105

1.83

1.64

1.1

—

Unspecified abortion

213

1.56

1.62

1.1

—

121.08

—

Tuberculosis of other organs, strict, including avohilmo

2.16

1.61

1.2

1.1

—

Other embolism and thrombosis

488

1.36

1.61

1.0

1.1

—

58.17

—

2.54

1.61

1.0

—

Exposure to other and unspecified man-made environmental factors

1.92

1.60

1.1

—

Other and unspecified disorders of psychological development

2.25

1.60

1.0

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

210

0.47

1.60

1.0

1.1

—

23.08

—

Iron deficiency

159

1.65

1.59

1.1

—

Psoas tendinitis

3.05

1.59

1.0

1.2

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

363

0.60

1.58

1.1

—

25.21

—

Occlusion and stenosis of arteries, not leading to stroke

2.71

1.58

1.3

1.1

—

Dermatophytosis, including avohilmo

425

3712

1.12

1.58

1.1

49.71

69.08

au/ml

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

719

0.72

1.57

1.1

—

54.17

—

Personal history of certain other diseases

1.87

1.57

1.2

1.1

—

Benign neoplasm: Spinal cord

2.13

1.56

1.4

1.1

—

Tic and related disorders

2.13

1.56

1.2

1.1

—

Xerosis cutis

2.13

1.55

1.1

—

Other specified and unspecified personality disorders

457

1.36

1.55

1.1

—

50.08

—

Psoriatic arthropathies

406

1.38

1.55

1.0

1.1

—

74.40

—

Other drug-induced secondary parkinsonism

2.46

1.54

1.0

1.1

—

Selective deficiency of immunoglobulin A [IgA]y

3.40

1.53

1.6

1.3

—

Listeriosis

3.40

1.53

1.2

1.1

—

Listeriosis, including avohilmo

3.39

1.53

1.2

1.1

—

Congenital nasolacrimal duct obstruction or stenosis, including avohilmo

3.39

1.53

1.0

—

Hypoplasia of dental enamel , including avohilmo

185

1.57

1.52

1.0

1.1

—

Neuroendocrine tumor and carcinoma of lung

2.63

1.52

1.0

1.1

—

Malignant neoplasm of breast

175

1344

0.84

1.51

1.1

—

86.61

—

ILD, hospital admission 2, with pulmonary infections

299

1.44

1.50

1.1

—

22.48

—

Acute otitis externa, noninfective

2.09

1.50

1.0

1.1

—

Helminthiases

2.02

1.49

1.1

—

Ulcer of vagina/vulva

116

1.74

1.49

1.1

—

Artrosis, including avohilmo

552

2732

1.11

1.49

1.1

43.43

62.61

au/ml

—

Melanoma in situ

139

1.66

1.48

1.1

—

Malignant neoplasm of breast, HER2-negative

175

1342

0.84

1.48

1.1

—

86.61

—

Later onset COPD

710

0.76

1.48

1.1

—

49.65

—

Hirsutism in women

1.83

1.48

1.1

—

Injury of nerves at forearm level

2.25

1.47

1.0

1.1

—

Motor disorders

2.01

1.47

1.0

1.1

—

Endometriosis of intestine

1.86

1.47

1.0

1.1

—

Drug-induced polyneuropathy

2.53

1.46

1.0

—

Malignant neoplasm of rectum

354

0.62

1.45

1.1

—

25.21

—

Enterobiasis, including avohilmo

102

1.78

1.45

1.0

1.1

—

Other hypertrichosis

3.21

1.45

1.2

1.1

—

Complications of anaesthesia during the puerperium

3.20

1.45

1.0

1.2

—

Adalimumab

524

1.32

1.44

1.1

—

66.29

—

Asymptomatic human immunodeficiency virus [HIV] infection status

2.77

1.44

1.0

1.1

—

Tularaemia

2.33

1.43

1.2

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

611

3520

1.10

1.43

1.1

55.75

70.18

au/ml

—

Medicines for HER+ breast cancer

137

1540

0.83

1.43

1.1

—

87.34

—

Abscess of anal and rectal regions

388

1.37

1.41

1.1

—

25.48

—

Other abnormal auditory perceptions

2.20

1.41

1.0

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

2.19

1.40

1.3

1.1

—

L02BA Anti-estrogens

692

0.74

1.40

1.2

1.1

—

104.81

—

Migraine, unspecified, drug-induced

2.45

1.40

1.0

1.1

—

Injury of nerves at ankle and foot level

2.45

1.40

1.1

1.2

—

Injuries to the elbow and forearm

464

3593

1.11

1.37

1.1

28.42

74.61

au/ml

—

Social disorders starting during childhood or adolecense, excluding more controls

2.64

1.37

1.0

1.1

—

Ulcerative colitis (strict) with PSC

0.00

1.34

0.0

1.1

—

Wegener granulomatosis

2.06

1.33

1.0

1.1

—

Tuberculosis of other organs, strict

2.05

1.33

1.2

1.1

—

Colorectal adenocarcinoma

710

0.75

1.33

1.1

—

48.79

—

Molar incisor enamel hypoplasia, with caries

2.44

1.31

1.0

1.1

—

Congenital hypothyroidism without goiter

2.55

1.31

1.0

1.1

—

Benign neoplasm: Orbit, unspecified

2.54

1.31

1.0

1.2

—

Malignant melanoma of skin

454

1.33

1.31

1.1

—

41.22

—

Intentional self-harm by hanging, strangulation and suffocation

2.53

1.31

1.2

1.1

—

Cutis laxa senilis

2.53

1.31

1.2

—

Lesion of femoral nerve

2.53

1.31

1.0

1.2

—

Exposure to uncontrolled fire in building or structure

2.53

1.31

1.2

1.1

—

Open wound of neck

2.53

1.31

1.0

1.2

—

Other other unspecified disorders of the circulatory system

129

1.64

1.30

1.0

1.1

—

Acquired haemolytic anaemia

1.85

1.30

1.1

—

Benign neoplasm: Pharynx, unspecified

2.39

1.30

1.3

1.1

—

Vascular dementia (undefined)

2.02

1.29

1.2

1.1

—

Congenital malformations of posterior segment of eye

2.82

1.29

1.0

1.2

—

Other congenital malformations of brain

2.82

1.29

1.0

1.1

—

Deformity of finger(s)

2.81

1.29

1.4

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

561

1.29

1.28

1.1

—

50.08

—

Other abnormalities of plasma proteins

2.02

1.28

1.0

1.1

—

Acute mastoiditis

2.31

1.27

1.0

1.1

—

Nonalcoholic steatohepatitis

2.31

1.27

1.0

1.1

—

Folate deficiency anaemia

2.31

1.27

1.1

—

Other noninflammatory disorders of vulva and perineum

474

1.31

1.27

1.1

—

61.18

—

Emergency coronary revascularization (for ACS)

488

2676

1.10

1.27

1.1

57.02

71.99

au/ml

—

Dermatitis due to ingested food

170

1.53

1.26

1.2

1.1

—

Peripheral artery disease

139

1305

0.84

1.25

1.1

—

68.58

—

Acute lymphocytic leukaemia, including Hilmo

2.26

1.25

1.1

—

Acute lymphocytic leukaemia, helper endpoint

2.26

1.25

1.1

—

Acute lymphocytic leukaemia

2.26

1.25

1.1

—

Congenital vesicoureteral reflux

2.43

1.25

1.0

1.2

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.43

1.25

1.2

1.1

—

Frostbite

2.24

1.25

1.0

1.1

—

Overexertion and strenuous or repetitive movements

467

1.31

1.24

1.0

1.1

—

43.00

—

Acute myeloid leukaemia and myelodysplastic syndromes

1.87

1.24

1.0

1.1

—

Perioral dermatitis

100

1.71

1.24

1.0

1.1

—

Other respiratory diseases principally affecting the interstitium

626

1.26

1.24

1.1

—

57.63

—

Neovascular glaucoma

131

1.61

1.23

1.0

1.1

—

Dyshidrosis [pompholyx]

1.92

1.23

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

121

1005

1.21

1.23

1.1

—

69.09

—

Unspecified transport accident

2.67

1.22

1.0

1.2

—

Sequelae of other and unspecified effects of external causes

2.67

1.22

1.0

1.2

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

2.67

1.22

1.0

—

Psoriatic and enteropathic arthropathies

495

1.30

1.22

1.0

1.1

—

74.40

—

Other and unspecified abdominal hernia

140

1.58

1.20

1.0

1.1

—

Other disorders starting during childhood or adolescence

269

1.40

1.19

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

2.34

1.19

1.2

1.0

—

Sequelae of poliomyelitis, including avohilmo

2.33

1.19

1.5

1.1

—

Dementia due to Parkinson's disease

1.89

1.18

1.1

—

Cholecystitis

515

1.28

1.18

1.1

—

60.85

—

Abnormal findings in nipple discharge synovial fluid wound secretions

1.95

1.17

1.1

—

Glaucoma secondary to other eye disorders

133

1.59

1.17

1.0

1.1

—

Heberden's nodes [with arthropathy]

0.00

1.16

0.0

1.1

—

Use of rotigotine

2.07

1.16

1.1

—

Cholinergic urticaria

2.54

1.16

1.0

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

1.74

1.15

1.1

—

Benign neoplasm: Brain, infratentorial

2.53

1.15

1.4

1.1

—

Multifocal fibrosclerosis

2.53

1.15

1.0

1.2

—

Other specified transport accidents

2.53

1.15

1.0

1.1

—

Toxic effect of carbon monoxide

1.86

1.14

1.1

—

Drug-induced obesity

2.02

1.12

1.0

1.1

—

Other and unspecified bullous disorders

2.02

1.12

1.0

1.1

—

Tibial collateral bursitis [Pellegrini-Stieda]

2.02

1.12

1.1

—

Other hammer toe(s) (acquired)

552

1.25

1.12

1.1

—

76.11

—

Malignant neoplasm of heart, mediastinum and pleura

2.02

1.12

1.0

1.1

—

Idiopathic thrombocytopenic purpura

111

1.63

1.12

1.0

1.1

—

Conduction disorders

149

1018

1.17

1.12

1.1

—

71.37

—

Hypertensive Heart Disease

101

630

1.22

1.12

1.1

—

74.81

—

Other protozoal intestinal diseases, including avohilmo

1.72

1.11

1.1

—

Other and unspecified diseases of blood and blood-forming organs

1.71

1.11

1.0

1.1

—

Other renal tubulo-interstitial diseases

1.72

1.11

1.1

—

HSIL lesion of the vulva

1.80

1.11

1.0

1.1

—

Presbyopia

345

1.34

1.11

1.1

—

50.08

—

Myocardial infarction

193

1544

0.87

1.10

1.1

76.22

76.48

au/ml

—

Marfan's syndrome

2.42

1.09

1.0

1.2

—

Maxillary prognathism

2.41

1.09

1.0

1.1

—

COPD-related respiratory insufficiency

363

1.33

1.09

1.2

1.1

—

52.56

—

Molar incisor enamel hypoplasia

200

1.44

1.09

1.0

1.1

—

Hypocalcemia

1.74

1.09

1.1

—

Other specified and unspecified disorders of eyelid

1.96

1.09

1.3

1.1

—

Sulfonylureas

931

0.83

1.08

1.1

—

54.30

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.14

1.06

1.3

1.1

—

Lumbosacral root disorders, not elsewhere classified

2.14

1.06

1.0

—

Melanocytic naevi of ear and external auricular canal

2.30

1.04

1.2

1.0

—

Hypertrophy of tongue papillae

1.85

1.03

1.0

1.1

—

Other and unspecified injuries of neck

2.08

1.03

1.1

—

Other protozoal intestinal diseases

1.85

1.03

1.1

—

Benign neoplasm: Bones of skull and face

2.08

1.03

1.0

1.1

—

Myelodysplastic syndrome

2.07

1.03

1.0

1.2

—

Peripheral arterial reconstruction

509

0.75

1.03

1.0

1.1

—

48.72

—

Mature T/NK-cell lymphomas, hilmo

1.93

1.02

1.0

1.1

—

Other specified and unspecified disorders of conjunctiva

2.02

1.00

1.1

—

Congenital malformations of uterus and cervix

1.63

1.00

1.1

—

Infections specific to the perinatal period

2.01

1.00

1.0

—

Nonalcoholic fatty liver disease

475

1.27

1.00

1.1

—

59.50

—

Oral lichen planus

107

1.60

1.00

1.1

—

Other superficial mycoses, including avohilmo

583

1.24

0.99

1.1

—

50.08

—

Dermatitis herpetiformis

1.82

0.99

1.1

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.98

0.0

1.2

—

Adenomyosis (Endometriosis of uterus)

610

1.23

0.98

1.2

1.1

—

61.18

—

Disorder of lipoprotein metabolism, unspecified

441

1.27

0.97

1.1

—

75.21

—

Melanocytic naevi of eyelid, including canthus

1.96

0.97

1.1

—

1.96

0.97

1.0

1.1

—

Von Willebrand disease

1.87

0.97

1.4

1.1

—

Chronic hepatitis NAS

1.81

0.97

1.2

1.1

—

Cellulitis of external ear

1.81

0.97

1.1

—

Cystic disease of liver

0.00

0.97

0.0

1.1

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.97

0.0

1.1

—

Infection due to other mycobacteria, including avohilmo

1.86

0.97

1.2

1.0

—

Infection due to other mycobacteria

1.81

0.97

1.2

1.0

—

Unequal limb length (acquired)

0.00

0.97

0.0

1.1

—

Complex cardiac defects

0.00

0.96

0.0

1.1

—

Accessory breast

0.00

0.95

0.0

1.1

—

Benign neoplasm: Duodenum

1.66

0.94

1.3

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

1.66

0.94

1.1

—

Atlantoaxial subluxation

2.25

0.94

1.0

—

Bus occupant injured in other and unspecified transport accidents

2.25

0.94

1.0

1.1

—

Respiratory tuberculosis, not confirmed

1.62

0.94

1.0

1.1

—

Certain zoonotic bacterial diseases, including avohilmo

109

1.57

0.93

1.1

—

Crystal arthropathies, rheuma endpoint

1.74

0.92

1.0

1.1

—

Hypertensive heart and/or renal disease

110

681

1.18

0.92

1.1

—

78.76

—

Other chromosome abnormalities, not elsewhere classified

2.18

0.92

1.0

1.1

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

1.83

0.92

1.0

1.1

—

Seminoma of testis

2.16

0.92

1.0

1.1

—

Blindness, monocular

2.16

0.92

1.2

1.1

—

Ulcer of lower limb, not elsewhere classified

526

1.24

0.91

1.1

—

68.02

—

Respiratory tuberculosis, not confirmed, including avohilmo

1.60

0.90

1.0

1.1

—

Perineal laceration during delivery

917

0.84

0.90

1.1

—

82.67

—

Autoimmune hepatitis

2.09

0.89

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

2.09

0.89

1.2

1.0

—

Mixed conductive and sensorineural hearing loss

447

1.26

0.89

1.1

—

47.48

—

Carcinoma in situ of breast, intraductal

313

0.70

0.89

1.1

—

85.00

—

Prurigo nodularis

1.65

0.88

1.2

1.1

—

Arthropathic psoriasis

511

1.24

0.88

1.0

1.1

—

102.17

—

Malignant neoplasm of corpus uteri

277

0.68

0.88

1.0

1.1

—

68.92

—

Anxious personality disorder

1.62

0.88

1.0

1.1

—

Other and unspecified aplastic anaemias

1.88

0.87

1.1

—

Colorectal cancer

856

0.83

0.87

1.1

—

51.02

—

Sequelae of intentional self-harm, assault and events of undetermined intent

2.02

0.87

1.3

1.1

—

Osteomalacia

2.02

0.87

1.5

1.1

—

Other congenital malformations, not elsewhere classified

2.02

0.87

1.0

1.1

—

Other disorders of choroid

1.83

0.86

1.1

—

Haemorrhagic and haematological disorders of fetus and newborn

1.64

0.86

1.0

—

malignant neoplasm of female genital organs, including Hilmo

660

0.81

0.85

1.1

—

80.96

—

Pleural effusion

504

1.23

0.85

1.1

—

43.59

—

Injury of nerves at shoulder and upper arm level

1.75

0.83

1.0

1.1

—

Other abnormal findings in urine

1.75

0.82

1.0

1.1

—

Tularaemia, including avohilmo

1.70

0.82

1.2

1.1

—

Other hereditary haemolytic anaemias

1.90

0.82

1.2

1.1

—

Intestinal adhesions without obstruction

319

1.29

0.82

1.0

1.1

—

23.46

—

Congenital malformations of the respiratory system

1.65

0.82

1.1

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.56

0.81

1.2

1.0

—

1.58

0.81

1.1

1.0

—

Systemic sclerosis

1.58

0.81

1.1

—

Other salmonella infections

130

1.47

0.81

1.0

1.1

—

malignant neoplasm of female genital organs

574

0.80

1.0

1.1

—

85.93

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.79

0.0

1.1

—

Unattended death

0.00

0.79

0.0

1.1

—

ILD medications: pirfenidone

0.00

0.79

0.0

1.1

—

Hydrocele

383

1.26

0.79

1.1

—

58.60

—

Contact with venomous snakes and lizards

1.68

0.79

1.4

1.1

—

Discontinuity and dislocation of ear ossicles

0.00

0.79

0.0

1.2

—

Respiratory tuberculosis, confirmed

1.67

0.79

1.0

1.1

—

Liveborn infants according to place of birth

1.81

0.78

1.2

1.0

—

ILD, hospital admissions 1, main diag only

475

1.22

0.77

1.1

—

25.21

—

Carcinoma in situ of vulva

1.78

0.76

1.0

1.1

—

Blepharospasm

1.78

0.76

1.0

1.1

—

Postdysenteric arthropathy

1.78

0.76

1.0

1.1

—

Adjustment and management of implanted device

576

1.20

0.76

1.1

—

52.76

—

Benign neoplasm: Other/unspecified site

1.71

0.75

1.0

1.1

—

LSIL lesion of the vagina

1.65

0.75

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

131

1108

0.88

0.75

1.1

—

78.28

—

Toxic effect of other gases, fumes and vapours

2.11

0.75

1.0

1.1

—

Galactorrhea

1.68

0.75

1.1

—

Benign neoplasm: Vagina

1.68

0.75

1.1

—

Achalasia of cardia

1.68

0.74

1.0

1.1

—

Other crystal arthropathies

1.67

0.74

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

132

1113

0.88

0.74

1.1

—

78.28

—

Other injuries of lower limb, level unspecified

1.86

0.74

1.0

1.1

—

Assault by other specified means

1.86

0.74

1.1

—

Toxic effect of other and unspecified substances

1.65

0.74

1.2

1.1

—

Pulmonary oedema

1.85

0.73

1.3

1.1

—

L02BG Aromatase inhibitors

111

1254

0.87

0.73

1.1

—

89.03

—

Juvenile Open Angle Glaucoma

2.02

0.73

1.2

—

Chronic Coagulation defects

100

1.51

0.73

1.3

1.1

—

Acute inflammation of orbit

2.02

0.73

1.2

1.1

—

Sequelae of poliomyelitis

2.02

0.73

1.6

1.0

—

Delayed puberty

2.01

0.73

1.4

1.1

—

Other bursitis of elbow

2.01

0.73

1.0

—

Calcific tendinitis

2.01

0.73

1.2

1.0

—

ILD, hospital admissions

524

1.20

0.73

1.1

—

25.21

—

Overjet

116

1.46

0.73

1.1

—

Spondylopathies in diseases classified elsewhere

1.81

0.72

1.0

1.1

—

Acute myeloid leukaemia, including Hilmo

1.81

0.72

1.0

1.1

—

Acute myeloid leukaemia

1.81

0.72

1.0

1.1

—

Acute myeloid leukaemia, helper endpoint

1.81

0.72

1.0

1.1

—

Gender identity disorders

1.62

0.72

1.0

1.1

—

Open wound of thorax

1.62

0.72

1.3

1.1

—

Sequelae of other accidents

1.62

0.72

1.0

1.1

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.62

0.72

1.0

1.1

—

Other congenital malformations of peripheral vascular system

1.68

0.72

1.0

1.1

—

Hereditary retinal dystrophy

1.68

0.72

1.2

1.1

—

Allergic contact dermatitis due to drugs in contact with skin

1.56

0.72

1.2

1.1

—

Other and unspecified acne

1.63

0.72

1.3

1.1

—

Localized skin eruption due to drugs and medicaments

1.76

0.71

1.0

1.1

—

Acute epiglottitis

1.59

0.71

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

607

3310

1.06

0.71

1.1

48.30

67.78

au/ml

—

Female infertility, associated with anovulation

462

1.22

0.71

1.1

—

57.68

—

Shigellosis, including avohilmo

1.94

0.71

1.0

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.94

0.71

1.0

1.1

—

Other specified and unspecified disorders of lens

1.94

0.71

1.0

1.1

—

Neonatal jaundice from other and unspecified causes

1.56

0.70

1.0

1.1

—

Colon adenocarcinoma

421

0.78

0.69

1.1

—

32.49

—

Malignant neoplasm of corpus uteri, including Hilmo

297

0.74

0.69

1.0

1.1

—

68.92

—

Cholelithiasis, broad definition with cholecystitis

519

3248

1.06

0.69

1.1

58.17

75.45

au/ml

—

Other disorders of cornea

400

1.23

0.69

1.0

1.1

—

51.18

—

Lung transplant status

1.87

0.69

1.6

1.1

—

Lung transplantation

1.87

0.69

1.6

1.1

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.68

0.68

1.0

1.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.53

0.68

1.2

1.1

—

Personal history of malignant neoplasm

338

1.25

0.67

1.1

—

102.17

—

Other interstitial pulmonary diseases

529

1.19

0.67

1.1

—

25.21

—

Amputation

320

1.25

0.67

1.1

—

23.82

—

Other congenital malformations of intestine

1.64

0.67

1.0

1.1

—

Phakomatoses, not elsewhere classified

1.64

0.67

1.0

1.1

—

Superficial injury of neck

1.50

0.67

1.2

1.1

—

Benign neoplasm: Anus and anal canal

1.50

0.67

1.2

1.1

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

1.80

0.66

1.0

1.1

—

Colon adenocarcinoma, helper endpoint

418

0.79

0.66

1.1

—

25.21

—

Interstitial lung disease endpoints

530

1.19

0.66

1.1

—

25.21

—

Interstitial lung disease

530

1.19

0.66

1.1

—

25.21

—

COPD

200

1476

1.10

0.66

1.1

—

74.09

—

Other retinal artery occlusion

1.58

0.65

1.1

—

Certain zoonotic bacterial diseases

1.62

0.65

1.2

1.1

—

Melanoma in situ of trunk

1.60

0.65

1.0

1.1

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.58

0.65

1.0

1.1

—

Amputation of thigh

1.62

0.65

1.0

1.1

—

173

1407

1.11

0.64

1.1

93.08

64.52

au/ml

—

Ovarian dysfunction, other/unspecified

1.74

0.64

1.0

1.1

—

Exposure to other and unspecified forces of nature

1.74

0.64

1.0

1.2

—

Congenital deformities of hip, including avohilmo

1.50

0.63

1.1

—

Acute bronchiolitis

251

1.26

0.63

1.0

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

387

1.22

0.62

1.1

—

20.95

—

Venous complications and haemorrhoids in the puerperium

1.64

0.62

1.1

—

Contusion of toe(s) with damage to nail

1.64

0.62

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

106

800

1.14

0.62

1.2

1.1

—

36.99

—

Other/unspecified rheumatoid arthritis

433

1.20

0.62

1.1

—

65.47

—

Traumatic ischaemia of muscle

1.64

0.62

1.4

1.1

—

Later onset COPD, excluding more controls

420

1.18

0.62

1.1

—

57.17

—

Leukaemia of unspecified cell type

1.68

0.61

1.0

1.1

—

Sequelae of tuberculosis, including avohilmo

1.67

0.61

1.0

—

Tuberculosis of other organs

1.61

0.61

1.3

1.1

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.61

0.0

1.1

—

Inguinal of femoral hernia, unilateral

1.48

0.60

1.0

1.1

—

Femoral hernia, unilateral

1.48

0.60

1.0

1.1

—

Inguinal hernia, unilateral

1.48

0.60

1.0

1.1

—

Burn and corrosion, body region unspecified

0.00

0.60

0.0

1.2

—

Contact with blunt object, undetermined intent

0.00

0.60

0.0

1.2

—

Malignant neoplasm of skin, including Hilmo

266

1647

1.08

0.60

1.1

131.38

49.97

au/ml

—

Granulosa cell carcinoma of ovary

0.00

0.60

0.0

1.1

—

Other dermatomyositis

0.00

0.59

0.0

1.0

—

Scissor bite

121

1.40

0.59

1.2

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.54

0.59

1.1

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

201

1.30

0.59

1.2

1.1

—

85.00

—

Congenital malformations of cardiac chambers and connections

0.00

0.58

0.0

1.0

—

Rhinophyma

0.00

0.58

0.0

1.1

—

Malignant neoplasm of palate, including Hilmo

0.00

0.58

0.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

159

1305

1.10

0.58

1.1

93.08

64.52

au/ml

—

Thiazolidinediones

400

1.20

0.58

1.1

—

20.52

—

Glaucoma secondary to eye inflammation

1.68

0.57

1.0

1.1

—

Primary ovarian failure

1.44

0.56

1.1

—

Social disorders starting during childhood or adolescence

1.63

0.56

1.0

1.1

—

Benign neoplasm: Parathyroid gland

1.63

0.55

1.0

1.1

—

Psoriatic arthropathies, ICD10

476

1.18

0.55

1.0

1.1

—

65.29

—

Systemic sclerosis, icd10

1.45

0.55

1.1

—

Congenital malformations of heart and great arteries

633

1.15

0.55

1.1

—

23.20

—

Hereditary deficiency of other clotting factors

1.59

0.54

1.3

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.47

0.54

1.1

1.0

—

Calcific aortic valvular stenosis, operated

928

0.88

0.54

1.1

—

52.36

—

Calcific aortic valvular stenosis

928

0.88

0.54

1.1

—

52.36

—

Congenital malformations of the respiratory system, including avohilmo

1.47

0.54

1.1

1.0

—

Coronary atherosclerosis

289

1951

0.93

0.54

1.1

58.20

68.58

au/ml

—

Distal bite

176

1.30

0.54

1.1

—

Operations 2 for CAVS

927

0.88

0.54

1.1

—

52.36

—

Calcific aortic valvular stenosis, diagnosis (helper)

927

0.88

0.54

1.1

—

52.36

—

Other chronic obstructive pulmonary disease

189

1421

1.09

0.53

1.1

—

72.03

—

Foreign body in genitourinary tract

1.55

0.53

1.2

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

175

1606

1.09

0.53

1.2

1.1

—

62.18

—

Glucagon-like peptide-1 (GLP-1) analogues

175

1606

1.09

0.53

1.2

1.1

—

62.18

—

Lichen planus

516

1.16

0.52

1.1

—

102.17

—

Cholelithiasis

493

3195

1.05

0.52

1.1

58.17

75.45

au/ml

—

Colorectal cancer, including Hilmo

945

0.89

0.52

1.1

—

49.49

—

Benign neoplasm: Stomach

350

1.20

0.52

1.0

1.1

—

23.46

—

Duodenal ulcer

350

1.20

0.52

1.0

1.1

—

19.67

—

Other chondrocalcinosis

1.51

0.51

1.0

1.1

—

Adult respiratory distress syndrome

1.51

0.51

1.2

1.1

—

Gastrojejunal ulcer

1.51

0.51

1.0

1.1

—

Tooth agenesis EXCLUDE clefts and syndromes

191

0.73

0.51

1.1

1.0

—

Other melanin hyperpigmentation

1.47

0.51

1.0

1.1

—

Aortic aneurysm

825

0.88

0.50

1.1

—

47.47

—

Calcific aortic valvular stenosis, including rheumatic fever

930

0.89

0.50

1.1

—

52.36

—

Pregnancy, childbirth and the puerperium

140

803

0.91

0.49

1.1

—

67.16

—

Ischaemic heart disease, wide definition

411

2396

1.06

0.49

1.1

78.50

67.43

au/ml

—

Myocardial infarction, with ST-elevation

551

0.85

0.49

1.1

—

41.26

—

COPD related to multimorbidity

163

1265

1.09

0.49

1.1

—

64.37

—

Non-small cell lung cancer, adenocarcinoma

190

1.27

0.48

1.0

1.1

—

23.70

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.50

0.47

1.0

1.1

—

Lichen simplex chronicus

128

1.33

0.47

1.0

1.1

—

Malignant neoplasm of breast, ER-negative, including Hilmo

822

0.89

0.47

1.0

1.1

—

72.11

—

Vitamin B12 deficiency anaemia

346

1.19

0.46

1.1

—

20.95

—

Abscess of external ear

1.43

0.46

1.0

1.1

—

Alcoholic liver disease

402

1.17

0.46

1.1

—

21.68

—

Benign neoplasm: Skin of upper limb, including shoulder

1.43

0.45

1.0

1.1

—

Respiratory disorders in diseases classified elsewhere

1.41

0.45

1.1

—

Shoulder region

1.40

0.45

1.0

1.1

—

Bullous pemphigoid

1.40

0.45

1.0

1.1

—

Bulimia nervosa (incl. atypical)

174

1.27

0.45

1.0

1.1

—

Retained placenta and membranes, without haemorrhage

581

1.14

0.45

1.1

—

102.17

—

Left hemicolectomy

1.45

0.44

1.2

1.1

—

Arteriovenous malformation of cerebral vessels

1.38

0.44

1.0

1.1

—

Defect, injury or illness of neck

1.63

0.43

1.0

1.1

—

Amoebiasis, including avohilmo

1.62

0.43

1.8

1.1

—

Mesial bite

1.62

0.43

1.0

1.1

—

Congenital deformities of hip

1.41

0.43

1.0

1.1

—

Other disorders affecting eyelid function

1.57

0.42

1.0

1.1

—

Gout due to impairment of renal function

1.57

0.42

1.0

1.1

—

Exophthalmic conditions

1.57

0.42

1.0

1.1

—

Unspecified kidney failure

322

1.18

0.42

1.1

—

30.21

—

Diseases caused by chlamydiae, including avohilmo

1.41

0.42

1.0

1.1

—

Malignant neoplasm of breast, HER-negative

765

0.89

0.42

1.0

1.1

—

72.11

—

Malignant neoplasm of bladder, including Hilmo

364

1.17

0.41

1.0

1.1

—

21.50

—

Failed attempted abortion

1.39

0.41

1.1

—

Macular cyst

1.36

0.41

1.2

1.1

—

Cleft lip

0.00

0.41

0.0

1.1

—

Melanoma in situ of lower limb, including hip

1.52

0.41

1.0

1.1

—

Benign neoplasm: Mediastinum

0.00

0.41

0.0

1.1

—

Primary amenorrhea

1.52

0.41

1.0

1.1

—

Other and unspecified water transport accidents

0.00

0.41

0.0

1.3

—

Postmenopausal atrophic vaginitis

126

628

1.09

0.41

1.2

1.1

109.00

76.32

au/ml

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.41

0.0

1.1

—

Interstitial cystitis (chronic), drug-induced

0.00

0.41

0.0

1.1

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.41

0.0

1.1

—

Pulmonary eosinophilia, not elsewhere classified

1.52

0.41

1.2

1.1

—

Atypical mycobacterium lung infection

1.52

0.41

1.4

1.1

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.41

0.0

1.0

—

Wilms' tumor, including Hilmo

0.00

0.41

0.0

1.2

—

Atrioventricular septal defect

0.00

0.41

0.0

1.0

—

Juvenile cataract

0.00

0.41

0.0

1.2

—

Pneumoconiosis due to asbestos and other mineral fibres

1.52

0.41

1.0

1.1

—

Paget disease

0.00

0.41

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.41

0.0

1.1

—

Dependence on enabling machines and devices, not elsewhere classified

1.51

0.41

1.2

1.0

—

Cardiomyopathy, other and unspecified

286

1.19

0.41

1.0

1.1

—

17.84

—

Other rupture of muscle

0.00

0.41

0.0

1.1

—

Corneal degeneration

1.36

0.41

1.0

1.1

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.1

—

Familial erythrocytosis

0.00

0.41

0.0

1.1

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.41

0.0

1.1

—

Valvular operations

519

0.87

0.40

1.1

—

45.19

—

Varicose veins

272

2172

0.94

0.40

1.1

76.26

75.41

au/ml

—

CR(E)ST syndrome

1.34

0.40

1.0

1.1

—

Other psoriatic arthropathies

464

1.14

0.40

1.0

1.1

—

65.29

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

0.40

0.0

1.1

—

Congenital aortic valve stenosis

0.00

0.40

0.0

1.1

—

Malignant neoplasm of gallbladder, including Hilmo

0.00

0.40

0.0

1.1

—

Delayed milestone in childhood

1.40

0.40

1.0

—

Autism spe, excluding more controls

1.36

0.39

1.0

1.1

—

Family history of malignant neoplasm

559

1.13

0.39

1.0

1.1

—

90.43

—

Cerebral palsy

1.32

0.39

1.3

1.1

—

Impacted maxillary canine

1.43

0.39

1.2

1.1

—

Androgenic alopecia

1.43

0.39

1.0

1.1

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.43

0.39

1.0

1.1

—

Melanoma in situ of other and unspecified parts of face

1.43

0.39

1.0

1.1

—

Disorders of puberty, all

1.41

0.39

1.2

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

115

1.31

0.39

1.1

—

Parapsoriasis

1.38

0.38

1.0

1.1

—

Oral lichen planus and hypothyroidism or thyroxine medication

1.37

0.38

1.0

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.39

0.38

1.0

1.1

—

Palindromic rheumatism

1.39

0.38

1.0

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

100

0.71

0.37

1.1

—

1.33

0.37

1.2

1.1

—

Injury of muscle and tendon at ankle and foot level

1.33

0.37

1.2

1.1

—

Lichen planus, including avohilmo

819

1.10

0.37

1.1

—

74.35

—

Malignant neoplasm of vulva

1.36

0.37

1.2

1.1

—

Iliotibial band syndrome

1.36

0.37

1.0

1.1

—

Fibrosis and cirrhosis of liver

300

0.83

0.36

1.1

—

23.20

—

COPD, hospital admission 2, with asthma infections

128

1020

1.08

0.36

1.1

—

63.73

—

Generalized epilepsy, strict definition

1.34

0.36

1.0

1.1

—

Venous complications and haemorrhoids in pregnancy

0.64

0.35

1.0

1.1

—

Pedal cyclist injured in noncollision transport accidents

574

1.12

0.35

1.1

—

66.91

—

Asthma and opportunity respiratory infection

135

1.26

0.35

1.1

—

Foreign body in ear

1.37

0.34

1.1

—

Mental retardation, excluding more controls

122

1.27

0.34

1.0

1.1

—

Ankyloglossia

1.37

0.34

1.2

1.1

—

Open bite that required surgery (Lefort1 or BSSO)

1.34

0.34

1.0

1.1

—

Prominent ears

1.31

0.33

1.0

1.1

—

Gestational [pregnancy-induced] hypertension

161

1509

1.07

0.32

1.1

—

62.64

—

Actinic keratosis

148

1260

1.07

0.32

1.1

93.08

59.37

au/ml

—

Striae atrophicae

1.28

0.32

1.0

1.1

—

Pedestrian injured in other and unspecified transport accidents

1.28

0.32

1.0

1.1

—

Chronic periodontitis, including avohilmo

611

3774

1.03

0.32

1.1

64.43

69.60

au/ml

—

Periodontitis

612

3776

1.03

0.32

1.1

64.43

69.60

au/ml

—

Unspecified lump in breast

712

1.10

0.32

1.1

—

104.81

—

Other pulmonary heart/vessel disease

128

1.25

0.32

1.3

1.1

—

Haemangioma, any site

370

1.14

0.31

1.0

1.1

—

49.20

—

Other congenital malformations of intestine, including avohilmo

1.33

0.31

1.0

1.1

—

AV-block

560

1.10

0.31

1.1

—

42.31

—

Psoriasis (vulgaris), strict definition

147

1.23

0.30

1.1

—

Pervasive developmental disorders excl. Autism + Asperger

1.31

0.30

1.0

1.1

—

Conductive hearing loss, unspecified

343

1.14

0.30

1.1

—

62.58

—

Disorders of globe

1.34

0.30

1.0

1.1

—

Pemphigoid

1.34

0.30

1.0

1.1

—

Congenital deformities of feet

111

1.26

0.30

1.1

—

Family history of other specific disorders

1.28

0.30

1.1

—

Rheumatic valve diseases

1.27

0.30

1.0

1.1

—

Postprocedural musculoskeletal disorders, not elsewhere classified

269

1.15

0.29

1.3

1.1

—

23.46

—

Premature separation of placenta [abruptio placentae]

106

0.75

0.29

1.1

—

Unspecified maternal hypertension

1.23

0.29

1.0

1.1

—

Thyroiditis, unspecified

1.23

0.29

1.3

1.1

—

Haemangioma and lymphangioma, any site

392

1.12

0.29

1.0

1.1

—

49.20

—

Malignant neoplasm of bladder

176

1.19

0.28

1.0

1.1

—

26.18

—

Other congenital malformations, including avohilmo

689

1.09

0.28

1.1

—

49.20

—

Other diseases caused by chlamydiae, including avohilmo

1.27

0.28

1.0

1.1

—

Disorders of puberty

1.25

0.27

1.3

1.1

—

Other congenital malformations of skin, including avohilmo

394

1.12

0.27

1.1

—

49.20

—

Family history of other conditions

1.23

0.27

1.1

1.0

—

Fracture of femur

100

840

1.07

0.27

1.1

—

46.28

—

Other congenital malformations of tongue, mouth and pharynx

1.21

0.26

1.3

1.1

—

Cleft lip, lip and palate or palate

0.70

0.26

1.0

1.1

—

Other blood glucose lowering drugs, excl. Insulins

558

1.09

0.26

1.2

1.1

—

68.59

—

Abnormalities of forces of labour

530

1.10

0.25

1.0

1.1

—

101.90

—

Malignant neoplasm of other connective and soft tissue

1.19

0.24

1.3

1.1

—

Allergic colitis

105

1.24

0.24

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

812

1.07

0.24

1.1

—

84.13

—

COPD, early/later onset

189

1515

1.05

0.24

1.1

—

68.44

—

Benign neoplasm: Other parts of oropharynx

1.32

0.23

1.0

1.1

—

Inflammation of lacrimal passages (chronic)

1.32

0.23

1.2

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

189

1764

1.05

0.23

1.1

—

62.64

—

Other diseases of appendix

1.29

0.23

1.0

1.1

—

Hypoplasia of dental enamel

1.28

0.23

1.0

1.1

—

Other assisted single delivery

1.25

0.22

1.0

1.1

—

Evidence of alcohol involvement determined by level of intoxication

1.25

0.22

1.0

1.1

—

Gastrointestinal stromal tumor and sarcoma

1.25

0.22

1.0

1.1

—

malignant neoplasm of male genital organs

109

696

0.94

0.22

1.1

72.86

26.14

au/ml

—

Peripheral artery operations in Hilmo

390

1.10

0.22

1.1

—

48.06

—

Major coronary heart disease event excluding revascularizations

275

1879

0.96

0.22

1.1

50.68

73.11

au/ml

—

Urticaria due to cold and heat

1.22

0.22

1.2

1.1

—

Dysplasia of cervi uteri

144

963

1.05

0.22

1.1

—

67.84

—

Benign neoplasm: Oesophagus

1.22

0.22

1.0

1.1

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.21

0.0

1.0

—

Ebstein's anomaly

0.00

0.21

0.0

1.2

—

Ependymoma

0.00

0.21

0.0

1.3

—

Diphtheria, including avohilmo

0.00

0.21

0.0

1.1

—

Microtia (small ears)

0.00

0.21

0.0

1.2

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.21

0.0

1.0

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.21

0.0

1.1

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.21

0.0

1.2

—

Fractures involving multiple body regions

0.00

0.21

0.0

1.3

—

Congenital malformations of anterior segment of eye

1.19

0.21

1.0

1.1

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.21

0.0

1.0

—

Noninfective disorders of pinna

0.00

0.21

0.0

1.0

—

Cystic fibrosis

0.00

0.21

0.0

1.0

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.21

0.0

1.1

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.21

0.0

1.1

—

Airway disease due to specific organic dust

0.00

0.21

0.0

1.0

—

Congenital lactase deficiency

0.00

0.21

0.0

1.3

—

Other acantholytic disorders

0.00

0.21

0.0

1.0

—

Non-seminoma of testis

0.00

0.21

0.0

1.2

—

Phantom limb syndrome

0.00

0.21

0.0

1.2

—

Intestinal helminthiases, other/unspecified, including avohilmo

0.00

0.21

0.0

1.1

—

Acquired atrophy of ovary and fallopian tube

0.00

0.21

0.0

1.0

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.21

0.0

1.2

—

Secondary systemic amyloidosis

0.00

0.21

0.0

1.1

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.21

0.0

1.2

—

Chondrosarcoma

0.00

0.21

0.0

1.2

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.21

0.0

1.2

—

Acute poliomyelitis

1.19

0.21

1.2

1.1

—

Acute poliomyelitis, including avohilmo

1.19

0.21

1.2

1.1

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.21

0.0

1.2

—

Rheumatic fever without mention of heart involvement

0.00

0.21

0.0

1.2

—

Benign neoplasm: Skin of lip

1.19

0.21

1.0

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.21

0.0

1.0

—

Enteropathogenic Escherichia coli infection

0.00

0.21

0.0

1.2

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.21

0.0

1.1

—

Defect, injury or illness of lumbar spine

0.00

0.21

0.0

1.3

—

Erectile dysfunction, exclusion

0.00

0.21

0.0

1.1

—

Other disorders following mastoidectomy

0.00

0.21

0.0

1.1

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.1

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.1

—

Nezelof syndrome

0.00

0.21

0.0

1.2

—

ILD medications: nintedanib

0.00

0.21

0.0

1.1

—

Bilateral cryptorchidism (undescended testicles)

0.00

0.21

0.0

1.0

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.21

0.0

1.2

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.0

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.2

—

Other secondary gout

0.00

0.21

0.0

1.0

—

Carcinoma in situ of breast

0.00

0.21

0.0

1.0

—

Malignant neoplasm of head and neck

283

0.88

0.21

1.2

1.1

—

27.94

—

Unspecified chronic bronchitis

103

0.78

0.21

1.1

—

Myotonic disorders

1.17

0.21

1.0

1.1

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

1.16

0.21

1.2

1.1

—

Drug-induced thyroiditis

0.00

0.21

0.0

1.2

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.0

—

Changes in corneal membranes

0.00

0.21

0.0

1.1

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.21

0.0

1.3

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.2

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.2

—

Gonarthrosis,primary

470

2761

1.03

0.20

1.1

30.07

83.44

au/ml

—

Chromosomal abnormalities, not elsewhere classified

1.24

0.20

1.1

—

Simple and mucopurulent chronic bronchitis

117

1.20

0.20

1.2

1.1

—

Lordosis

0.00

0.20

0.0

1.2

—

Chronic respiratory disease originating in the perinatal period

0.00

0.20

0.0

1.1

—

Chronic thyroiditis

0.00

0.20

0.0

1.2

—

Complications specific to multiple gestation

0.00

0.20

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.25

0.20

1.5

1.1

—

Other disorders of amino-acid metabolism

0.00

0.20

0.0

1.1

—

Malignant neoplasm of base of tongue

0.00

0.20

0.0

1.1

—

Malignant neoplasm of skin

235

1534

1.04

0.20

1.1

131.38

49.97

au/ml

—

Carcinoma in situ, bladder

113

0.80

0.20

1.0

1.1

—

Mandibular retrognathia AND surgery (BSSO)

114

0.79

0.20

1.0

1.1

—

Polyhydramnios

269

1.12

0.19

1.1

—

Medical treatment for female infertility

129

1339

0.95

0.19

1.1

—

75.04

—

Malignant neoplasm of colon

541

0.92

0.19

1.1

—

46.37

—

Localized scleroderma [morphea]

1.18

0.19

1.0

1.1

—

Hypersensitivity pneumonitis due to organic dust

1.18

0.19

1.3

1.1

—

Nontoxic single thyroid nodule

281

0.89

0.19

1.0

1.1

—

74.17

—

Poor fetal growth

757

0.94

0.19

1.1

—

46.48

—

Malignant neoplasm of stomach, including Hilmo

175

0.86

0.19

1.0

1.1

—

21.90

—

Benign neoplasm: Other and unspecified parts of small intestine

1.13

0.18

1.2

1.1

—

Granuloma annulare

1.13

0.18

1.0

1.1

—

Aortic valve malfunction, age under 60 years

436

0.92

0.18

1.1

—

50.08

—

HSIL lesion of the vagina

1.19

0.18

1.1

—

Hydatidiform mole

1.17

0.18

1.0

1.1

—

malignant neoplasm of male genital organs, including Hilmo

113

712

0.95

0.17

1.1

72.86

26.14

au/ml

—

Asymmetry of jaw

1.15

0.17

1.0

1.1

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.72

0.17

1.0

1.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

464

0.93

0.16

1.1

—

50.08

—

Benign neoplasm of mouth and pharynx

437

1.08

0.16

1.1

—

19.67

—

conjunctival degenerations and deposits

1.13

0.16

1.0

1.1

—

Excessive earwax

342

3025

1.02

0.16

1.1

31.09

73.08

au/ml

—

Whooping cough, including avohilmo

0.78

0.15

1.0

1.1

—

Chronic mastoiditis

1.16

0.15

1.0

1.1

—

Inguinal hernia

304

2070

0.98

0.15

1.1

49.67

62.03

au/ml

—

Other disorders of breast and lactation associated with childbirth

1.13

0.15

1.1

—

Dependent personality disorder

1.13

0.15

1.1

—

Epiphora

1.13

0.15

1.0

1.1

—

Acute posthaemorrhagic anaemia

102

1.18

0.15

1.0

1.1

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

1.09

0.14

1.2

1.1

—

COPD, hospital admissions

185

1510

1.03

0.14

1.1

—

68.44

—

Use of rasagiline

0.81

0.14

1.0

1.1

—

Seronegative juvenile rheumatoid arthritis

0.78

0.14

1.1

—

Congenital malformations of breast, including avohilmo

0.78

0.14

1.0

1.1

—

Primary gonarthrosis, bilateral

234

1906

1.03

0.14

1.1

—

77.74

—

HSIL lesion of the cervix uteri

106

1104

0.96

0.14

1.1

—

68.30

—

Stenosis and insufficiency of lacrimal passages

343

1.08

0.14

1.2

1.1

—

43.22

—

Artificial joint re-operation

227

1.10

0.14

1.1

—

23.46

—

Arterial embolism and thrombosis of lower extremity artery

0.82

0.13

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

191

1333

0.97

0.13

1.1

123.04

51.86

au/ml

—

Puerperal sepsis

559

1.06

0.13

1.0

1.1

—

102.17

—

Idiopathic urticaria

107

0.84

0.13

1.0

1.1

—

Other appendicitis

374

1.07

0.13

1.1

—

87.48

—

Labour and delivery complicated by fetal stress [distress]

160

1072

0.97

0.12

1.1

—

94.00

—

Benign neoplasm: Rectosigmoid junction

137

0.87

0.12

1.2

1.1

—

Postpartum haemorrhage due to anatomy

639

0.95

0.11

1.1

—

46.48

—

Erectile dysfunction

250

1.08

0.11

1.2

1.1

—

23.82

—

Macular pucker

563

1.05

0.11

1.1

—

52.46

—

In situ neoplasms

192

1876

1.02

0.10

1.1

—

63.93

—

Unstable angina pectoris

144

1162

0.97

0.10

1.1

82.64

77.28

au/ml

—

Postpartum haemorrhage due to retained placenta

729

0.96

0.10

1.0

1.1

—

88.49

—

Hypertrophy of breast

881

0.96

0.10

1.1

—

88.43

—

Other congenital malformations of female genitalia

1.14

0.10

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

1.14

0.10

1.2

1.1

—

Carcinoma in situ of rectum

1.14

0.10

1.0

—

Other immunodeficiencies

1.11

0.10

1.2

1.1

—

Benign neoplasm: Bronchus and lung

1.11

0.10

1.2

1.1

—

Carcinoma in situ of breast, other/unspecified

1.11

0.10

1.2

1.0

—

Migraine with aura, drug-induced

1.09

0.09

1.0

1.1

—

All dysplastic lesions of the cervix uteri

158

1592

0.98

0.09

1.1

—

62.64

—

Ovarian hyperstimulation (induction)

1.15

0.09

1.0

1.1

—

Spinal enthesopathy

1.06

0.09

1.0

1.1

—

Other and/or unspecified nontoxic goitre

291

1.07

0.09

1.0

1.1

—

85.00

—

Secondary right heart disease

116

1.12

0.09

1.3

1.1

—

Angina pectoris

258

1741

0.98

0.09

1.1

113.37

68.58

au/ml

—

Universal erythroderma, KELA reimbursement

1.11

0.09

1.0

1.1

—

Osteonecrosis due to drugs

1.11

0.09

1.0

1.1

—

Abscess of lung

1.09

0.09

1.0

1.1

—

Portal vein thrombosis

1.09

0.09

1.0

1.1

—

Postpartum hemorraghe, parous women as controls

162

1325

1.02

0.08

1.1

—

67.90

—

Carcinoma in situ of cervix uteri, endocervix

1.07

0.08

1.0

1.1

—

Guttate psoriasis

1.07

0.08

1.0

1.1

—

COPD, hospital admissions 1, only main diagnosis

123

1084

0.97

0.08

1.1

—

64.10

—

Anorexia

1.07

0.08

1.0

1.1

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.07

0.08

1.0

1.1

—

Short stature, not elsewhere classified

1.12

0.08

1.2

1.1

—

Deep bite that required surgery

1.05

0.08

1.2

1.1

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

587

1.04

0.08

1.1

—

20.52

—

Vitiligo

1.03

0.08

1.2

1.1

—

Central retinal artery occlusion

1.03

0.08

1.0

1.1

—

Mixed specific developmental disorders

1.13

0.08

1.1

—

Primary biliary cholangitis (PBC)

0.78

0.08

1.0

1.1

—

Other specified/unspecified spondylopathies

0.78

0.08

1.0

1.1

—

Respiratory distress of newborn

1.10

0.08

1.1

1.0

—

Other congenital malformations of ear

1.08

0.08

1.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

588

1.04

0.08

1.0

1.1

—

73.14

—

1.06

0.08

1.3

1.1

—

Mixed disorders of conduct and emotions

127

1.10

0.08

1.1

—

Malignant neoplasm of cervix uteri

0.86

0.07

1.2

1.1

—

Benign neoplasm: Lip

0.82

0.07

1.0

1.1

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.80

0.07

1.0

1.1

—

Other and unspecified mental retardation

1.09

0.07

1.0

1.1

—

Accidental poisoning by and exposure to alcohol

1.07

0.07

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

121

1183

1.02

0.07

1.1

—

68.30

—

Congenital malformations of breast

0.86

0.07

1.0

1.1

—

Juvenile rheumatoid arthirtis

1.05

0.07

1.1

—

Pterygium

0.86

0.06

1.3

1.1

—

Malignant neoplasm of colon, including Hilmo

648

1.03

0.06

1.1

—

41.53

—

Postpartum hemorraghe, all women as controls

162

1554

1.02

0.06

1.1

—

68.14

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

223

0.94

0.06

1.3

1.1

—

13.62

—

Autism spe

131

0.92

0.05

1.0

1.1

—

Other menopausal disorders

140

767

1.02

0.05

1.1

—

67.41

—

Basal cell carcinoma

187

1291

0.99

0.05

1.1

123.04

51.86

au/ml

—

Pleural plaque

272

0.96

0.04

1.1

—

63.98

—

Thoracic aortic aneurysm

556

1.03

0.04

1.1

—

39.79

—

Inguinal or femoral hernia, bilateral

388

1.03

0.04

1.1

—

62.90

—

Inguinal hernia, bilateral

379

1.03

0.03

1.1

—

62.90

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

410

0.98

0.02

1.1

—

121.08

—

Disorders of eyelid in diseases classified elsewhere

127

0.94

0.01

1.0

1.1

—

LSIL lesion of the cervix uteri

678

0.99

0.01

1.1

—

89.57

—

Basal cell carcinoma, including Hilmo

200

1347

1.00

0.01

1.1

123.04

51.86

au/ml

—

Autism

126

0.95

0.01

1.0

1.1

—

Other disorders of bone density and structure

104

1.06

0.01

1.0

1.1

—

Left bundle-branch block

278

1.01

0.00

1.2

1.1

—

44.41

—

Malignant neoplasm of head and neck, including Hilmo

341

1.00

0.00

1.1

—

25.21

—

111

1.03

0.00

1.0

—

Hypertrophy of breast in women and men

101

1012

1.00

0.00

1.1

—

79.88

—

0.99

0.00

1.0

—

Benign neoplasm: Pancreas

1.04

0.00

1.1

—

Granulomatous disorders of skin and subcutaneous tissue

102

0.98

0.00

1.0

1.1

—

Benign mammary dysplasia

563

0.99

0.00

1.1

—

104.61

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

209

1408

1.00

0.00

1.1

123.04

51.86

au/ml

—

Postpartum haemorrhage

162

1334

1.00

0.00

1.1

—

78.45

—

Carcinoma in situ of colon

103

0.97

0.00

1.2

1.1

—

Isolated proteinuria

105

0.95

0.00

1.1

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.3

—

Choroidal detachment

0.00

0.0

1.0

—

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

0.00

0.0

1.0

—

ILD medications: acetylcysteine

0.00

0.0

1.1

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.0

—

Acne varioliformis

0.00

0.0

1.4

—

Cholera, including avohilmo

0.00

0.0

1.5

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.0

—

Hypotony of eye

0.00

0.0

1.0

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.4

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

1.0

—

Cardiomyopathy due to drugs and other external agents

0.00

0.0

1.0

—

Nephropathy induced by other drugs, medicaments and biological substances

0.00

0.0

1.0

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

Other fibroblastic disorders

0.00

0.0

1.0

—

Pectus carinatum

0.00

0.0

1.3

—

Drug-induced hypopituitarism

0.00

0.0

1.2

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.88

0.00

1.2

1.1

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.0

—

Other nonscarring hair loss

1.02

0.00

1.0

1.1

—

Hereditary factor VIII deficiency

0.00

0.0

1.0

—

Single ventricle heart

0.00

0.0

1.0

—

Alport

0.00

0.0

1.3

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites

0.96

0.00

1.2

1.1

—

Plasmodium falciparum malaria, including avohilmo

0.00

0.0

1.0

—

Malignant neoplasm of vulva, including Hilmo

1.02

-0.00

1.2

1.1

—

Folliculitis decalvans

0.00

-0.00

0.0

1.0

—

Chronic constrictive pericarditis

0.00

-0.00

0.0

1.0

—

Malignant otitis externa

0.00

-0.00

0.0

1.0

—

Respiratory conditions due to other external agents

0.88

-0.00

1.0

1.1

—

Pemphigus vulgaris

0.00

-0.00

0.0

1.0

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.2

—

Postinflammatory hyperpigmentation

0.00

-0.00

0.0

1.4

—

Maxillary retrognathism

1.00

-0.00

1.1

—

Calcinosis cutis

0.00

-0.00

0.0

1.0

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.0

—

Other and unspecified cicatricial alopecia

0.00

-0.00

0.0

1.0

—

Unspecified hairloss

0.00

-0.00

0.0

1.0

—

Pemphigus foliaceus

0.00

-0.00

0.0

1.0

—

Perichondritis of external ear

1.02

-0.00

1.6

1.1

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.0

—

Other disorders of bone development and growth

0.00

-0.00

0.0

1.4

—

Other conjunctival vascular disorders and cysts

1.00

-0.00

1.0

1.1

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.0

—

Disorders of vagus nerve

0.00

-0.00

0.0

1.0

—

Juvenile dermatomyositis

0.00

-0.00

0.0

1.3

—

Other hypertrophic osteoarthropathy

0.00

-0.00

0.0

1.0

—

Knuckle pads

0.00

-0.00

0.0

1.0

—

Induced delusional disorder

0.00

-0.00

0.0

1.0

—

Other recurrent vertebral subluxation

0.00

-0.00

0.0

1.3

—

ILD-related respiratory insufficiency

0.93

-0.00

1.2

1.1

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

0.00

-0.00

0.0

1.4

—

Disorders of tyrosine metabolism

0.00

-0.00

0.0

1.0

—

Disorders of urea cycle metabolism

0.00

-0.00

0.0

1.0

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.4

—

Lipoprotein deficiency

0.00

-0.00

0.0

1.2

—

Iodine-deficiency-related goitre

0.00

-0.00

0.0

1.0

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.92

-0.00

1.0

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

-0.00

0.0

1.0

—

Drug-induced aplastic anaemia

0.00

-0.00

0.0

1.0

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Hyperchylomicronaemia

0.00

-0.00

0.0

1.1

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.0

—

Hirsprung

0.00

-0.00

0.0

1.0

—

Other congenital malformations of eye

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of lower limb, including hip

0.97

-0.00

1.0

1.1

—

Carcinoma in situ of skin of upper limb, including shoulder

1.01

-0.00

1.0

1.1

—

Congenital glaucoma

0.00

-0.00

0.0

1.0

—

Drug-induced gout

0.00

-0.00

0.0

1.0

—

Use of levodopa decarbox-comt-inhibitor

0.96

-0.00

1.0

1.1

—

Osteogenesis imperfecta

0.00

-0.00

0.0

1.3

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.0

—

Ventricular septal defect, a heart condition

0.94

-0.00

1.0

1.1

—

Supernumerary ureter

0.00

-0.00

0.0

1.3

—

Noonan syndrome

0.00

-0.00

0.0

1.3

—

Other and unspecified haemorrhagic conditions

0.94

-0.00

1.0

1.1

—

Pulmonary artery stenosis

0.00

-0.00

0.0

1.0

—

Melanoma in situ of scalp and neck

0.00

-0.00

0.0

1.0

—

Hereditary lymphedema, including avohilmo

0.00

-0.00

0.0

1.3

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.4

—

Exclusion endpoint for clefts

0.98

-0.00

1.0

1.1

—

Benign neoplasm: Urethra

0.00

-0.00

0.0

1.2

—

Congenital heart conduction disorder

0.00

-0.00

0.0

1.1

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of penis

0.00

-0.00

0.0

1.1

—

Fusion of the labia, including avohilmo

0.00

-0.00

0.0

1.0

—

Lumbosacral spina bifida and hydrocephalus

0.00

-0.00

0.0

1.3

—

Turner's syndrome

0.00

-0.00

0.0

1.3

—

Spina bifida

0.00

-0.00

0.0

1.3

—

Hereditary lymphedema

0.00

-0.00

0.0

1.3

—

Follicular keratosis (Darier-White), including avohilmo

0.00

-0.00

0.0

1.4

—

Polydactyly

0.00

-0.00

0.0

1.2

—

Other specified congenital malformation syndromes affecting multiple systems

0.93

-0.00

1.0

1.1

—

Asphyxiation

0.00

-0.00

0.0

1.3

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.99

-0.00

1.1

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.4

—

Fracture of spine, level unspecified

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

-0.00

0.0

1.0

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of trachea, including Hilmo

0.00

-0.00

0.0

1.0

—

Cyst of spleen

0.00

-0.00

0.0

1.3

—

Injury of heart

0.00

-0.00

0.0

1.3

—

Melanocytic naevi of scalp and neck

0.97

-0.00

1.0

1.1

—

Disorders of amino-acid transport

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.0

—

Injury of blood vessels at ankle and foot level

0.00

-0.00

0.0

1.0

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.1

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

Vascular dementia (sudden onset)

0.00

-0.00

0.0

1.0

—

Assault by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.0

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.93

-0.00

1.0

1.1

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.89

-0.00

1.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.02

-0.00

1.0

1.1

—

Malignant neoplasm of small intestine

0.99

-0.00

1.0

1.1

—

Malignant neoplasm of eye and adnexa, including Hilmo

1.02

-0.00

1.0

1.1

—

Exposure to high and low air pressure and changes in air pressure

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of oropharyng

0.00

-0.00

0.0

1.1

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

1.3

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

1.0

—

Other leukaemias of specified cell type

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.1

—

Other helminthiases

0.00

-0.00

0.0

1.0

—

Medullary carcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

-0.00

0.0

1.0

—

Squamous cell neoplasms and carcinoma of rectum

0.00

-0.00

0.0

1.0

—

Sickle-cell disorders

0.00

-0.00

0.0

1.2

—

Other porphyria

0.00

-0.00

0.0

1.0

—

Intentional self-harm by drowning and submersion

0.00

-0.00

0.0

1.3

—

Rheumatic heart disease, other

0.00

-0.00

0.0

1.3

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.0

—

Other respiratory conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Solar urticaria

0.00

-0.00

0.0

1.2

—

Paranoid personality disorder

0.94

-0.00

1.0

1.1

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

1.0

—

Amputation of foot

0.96

-0.00

1.0

1.1

—

Convulsions of newborn

0.00

-0.00

0.0

1.0

—

Transepidermal elimination disorders

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

-0.00

0.0

1.4

—

Profound mental retardation

0.00

-0.00

0.0

1.0

—

Traumatic secondary and recurrent haemorrhage

0.00

-0.00

0.0

1.0

—

Rheumatic fever incl heart disease

1.00

-0.00

1.0

1.1

—

Cystic fibrosis with pulmonary manifestations

0.00

-0.00

0.0

1.0

—

Dengue, including avohilmo

0.00

-0.00

0.0

1.3

—

Diphtheria

0.00

-0.00

0.0

1.1

—

Hypergammalglobulinemia, unspecified

0.00

-0.00

0.0

1.0

—

Other parasitologically confirmed or unspecified malaria, including avohilmo

0.00

-0.00

0.0

1.0

—

Lichen striatus

0.00

-0.00

0.0

1.2

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

1.3

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.0

—

Cystic fibrosis, other manifestations/unspecified

0.00

-0.00

0.0

1.0

—

Myiasis, including avohilmo

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Renal pelvis

0.00

-0.00

0.0

1.0

—

Obstetric embolism

0.00

-0.00

0.0

1.0

—

Abnormalities of ear ossicles

0.00

-0.00

0.0

1.0

—

Cystic fibrosis with intestinal manifestations

0.00

-0.00

0.0

1.0

—

Cholera

0.00

-0.00

0.0

1.4

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.94

-0.00

1.0

—

Nutritional marasmus

0.00

-0.00

0.0

1.0

—

Multiple congenital exostoses, including avohilmo

0.00

-0.00

0.0

1.3

—

Other localized connective tissue disorders

0.99

-0.00

1.0

1.1

—

Multiple congenital exostoses

0.00

-0.00

0.0

1.3

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

-0.00

0.0

1.3

—

Polyp of middle ear

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS